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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 96 (FGE.96):  
Consideration of 88 flavouring substances considered by EFSA for which 
EU production volumes / anticipated production volumes have been 
submitted on request by DG SANCO1 
Addendum to FGE. 51, 52, 53, 54, 56, 58, 61, 62, 63, 64, 68, 69, 70, 71, 73, 
76, 77, 79, 80, 83, 84, 85 and 87. 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to consider evaluations of flavouring substances assessed since 
2000 by the Joint FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide 
whether further evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000. 
The present FGE.96 concerns 88 JECFA-evaluated substances from different FGEs. Common for all 
the 88 substances was that for none of them European production volumes were available at the time 
for the first consideration of the FGEs in question. As a consequence, no MSDI could be calculated for 
EU and accordingly the substances could not be considered by EFSA using the evaluation Procedure. 
Industry has now provided production volumes for these substances. Based on these newly provided 
production figures, MSDI values for EU have been calculated and based on these MSDI values the 
substances have been re-considered by the stepwise approach (the Procedure) that integrates 
information on structure-activity relationships, intake from current uses, toxicological threshold of 
concern, and available data on metabolism and toxicity. In the FGEs in question, genotoxicity of the 
                                                     
 
1  On request from the Commission, Question No EFSA-Q-2010-01246, adopted on 25 November 2010. 
2  Panel members: Arturo Anadon, Mona-Lise Binderup, Wilfried Bursch, Laurence Castle, Riccardo Crebelli, Karl-Heinz 
Engel, Roland Franz, Nathalie Gontard, Thomas Haertle, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean 
Claude Lhuguenot, Wim Mennes, Maria Rosaria Milana, Karla Pfaff, Kettil Svensson, Fidel Toldra, Rosemary Waring, 
Detlef Wölfle. Correspondence: cef-unit@efsa.europa.eu  
3  Acknowledgement: The Panel wishes to thank the members of the Working Groups on Flavourings for the preparation of 
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Rainer Gürtler, Frances Hill, Trine Husøy, John Christian Larsen, Pia Lund, Wim Mennes, Gerard Mulder, Karin Nørby, 
Gerard Pascal, Iona Pratt, Gerrit Speijers, Harriet Wallin and EFSA’s staff member Kim Rygaard Nielsen for the 
preparatory work on this scientific Opinion. 
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substances considered in FGE.96 has already been addressed. For none of the substances a concern for 
genotoxicity was identified. The Panel concluded that 87 of the substances do not give rise to safety 
concerns at the levels of dietary intake, estimated on the basis of the MSDI approach. However, for the 
substance 2-acetyl-1-ethylpyrrole [FL-no: 14.045], the Panel could not identify an appropriate 
NOAEL and accordingly additional data are required. Besides the safety assessment of these 
flavouring substances, the specifications for the materials of commerce have also been considered and 
for eight stereoisomeric substances [FL-no: 06.040, 08.073, 09.371, 09.780, 10.050, 13.060, 13.161 
and 16.039], the stereoisomeric composition has to be specified further.  
 
© European Food Safety Authority, 2011 
KEY WORDS 
Footnote 8, European anticipated production volume, MSDI. 
SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to consider the Joint FAO/WHO Expert 
Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000. These flavouring substances are listed in the Register, which was adopted by 
Commission Decision 1999/217/EC and its consecutive amendments. 
The present FGE.96 concerns 88 JECFA-evaluated substances from different groups. These groups 
have been previously considered by EFSA in FGE.51, 52, 53, 54, 56, 58, 61, 62, 63, 64, 68, 69, 70, 
71, 73, 76, 77, 79, 80, 83, 84, 85 and 87. Common for all the 88 substances was that for none of them 
European production volumes were available at the time for the first consideration in the above-
mentioned FGEs. As a consequence, no MSDI could be calculated for EU and accordingly the 
substances could not be considered by EFSA using the Procedure. 
By February/April 2010 Industry provided production volumes for these substances. Based on these 
newly provided (anticipated) production figures, MSDI values for EU have been calculated (see Table 
1.1 and Table 2), and based on these MSDI values the substances have been re-considered by EFSA in 
the current FGE.96. For the flavouring substances for which the production volumes are anticipated 
figures, the present evaluation will have to be reconsidered when actual production volumes become 
available. 
In the FGEs mentioned above, genotoxicity of the substances considered in FGE.96 has already been 
addressed. For none of the substances a concern for genotoxicity was identified. 
The Panel has considered 87 of the JECFA evaluated substances to be of no safety concern when used 
at the estimated intake based on the MSDI approach. For the remaining substance, 2-acetyl-1-
ethylpyrrole [FL-no: 14.045] the Panel could not identify an appropriate NOAEL and accordingly 
additional data are required.  
In order to determine whether the conclusion for the 88 JECFA-evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity tests are available for 79 of the JECFA-
evaluated substances. For [FL-no: 15.008], the solubility in water is missing. Otherwise the 
specifications for this substance are appropriate. For eight stereoisomeric substances [FL-no: 06.040, 
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08.073, 09.371, 09.780, 10.050, 16.039, 13.060 and 13.161], the stereoisomeric composition has to be 
specified further.  
Thus, for 79 of the 88 substances, the Panel concluded that they would be of no safety concern when 
used at their estimated levels of intake as flavouring substances based on the MSDI approach. For 
eight of the remaining nine substances, additional data on stereochemical composition are required to 
finalise their evaluation as material of commerce. For [FL-no: 14.045] additional toxicity data are 
required to finalise the evaluation. 
The Panel noted that amino acids [FL-no: 16.056, 17.001, 17.003, 17.015 and 17.026] may react with 
other food constituents upon heating. The reaction mixtures formed are commonly referred to as 
“process flavours” which have not been evaluated by the Panel. The present evaluation is therefore on 
the basis that the present flavouring substances are in an unchanged form when they are consumed, 
thus in food that is not intended to be heated 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a).  
Commission Regulation (EC) No 1565/2000 lays down that substances that are contained in the 
Register and will be classified in the future by the Joint FAO/WHO Expert Committee on Food 
Additives (the JECFA) so as to present no safety concern at current levels of intake will be considered 
by the European Food Safety Authority (EFSA), who may then decide that no further evaluation is 
necessary. 
In the period 2000 – 2008, during its 55th, 57th, 59th, 61st, 63rd, 65th, 68th and 69th meetings, the JECFA 
evaluated about 1000 substances, which are in the EU Register. 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to consider the JECFA evaluations of 
flavouring substances assessed since 2000, and to decide whether no further evaluation is necessary, as 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a). These flavouring substances 
are listed in the Register which was adopted by Commission Decision 1999/217 EC (EC, 1999a) and 
its consecutive amendments. 
ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), hereafter named the “EFSA Procedure”. 
This Procedure is based on the Opinion of the Scientific Committee on Food (SCF, 1999a), which has 
been derived from the evaluation Procedure developed by the Joint FAO/WHO Expert Committee on 
Food Additives (JECFA, 1995; JECFA, 1996a; JECFA, 1997a; JECFA, 1999b), hereafter named the 
“JECFA Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (the Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be put through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
In its evaluation, the Panel as a default uses the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
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by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006c). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 microgram per 
person per day would not be expected to present a safety concern. The Committee recommended that 
the Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be 
amended to include the last step on the right-hand side of the original procedure (“Do the condition of 
use result in an intake greater than 1.5 microgram per day?”) (JECFA, 1999b).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 microgram per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999a), the Panel has in its evaluation focussed on a 
possible genotoxic potential of the flavouring substances or of structurally related substances. 
Generally, substances for which the Panel has concluded that there is an indication of genotoxic 
potential in vitro, will not be evaluated using the EFSA Procedure until further genotoxicity data are 
provided. Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated 
through the Procedure. 
 
Specifications 
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Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA-evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
HISTORY OF THE EVALUATION OF THE SUBSTANCES IN THE PRESENT FGE 
The present FGE.96 concerns 88 JECFA-evaluated substances evaluated in different JECFA groups 
and former been considered by EFSA in FGE. 51, 52, 53, 54, 56, 58, 61, 62, 63, 64, 68, 69, 70, 71, 73, 
76, 77, 79, 80, 83, 84, 85 and 87.  
In the FGEs mentioned above, genotoxicity of the substances considered in FGE.96 has been 
addressed. For none of the substances a concern for genotoxicity was identified. 
Common for all 88 substances considered by EFSA in the above mentioned FGEs was that no 
European production volumes were available at the time for the first consideration of the FGEs. As no 
European production volumes were available no MSDI could be calculated for EU and accordingly the 
substances could not be considered by EFSA using the Procedure. 
By February 2010 Industry provided production volumes for these 88 substances. For 27 of the 
substances the provided production figure origins from the EFFA European survey conducted in 2004 
and for 55 of the provided production volumes the figure is anticipated (EFFA, 2010c). For the 
remaining six substances it has not been stated if the figures are from an European survey or 
anticipated production volumes (EFFA, 2010a) (see Table 1.1). 
Based on the provided (anticipated) production figures MSDI for EU have been calculated (see Table 
1.1), and based on these MSDI values the 88 substances will be re-considered by EFSA along the 
Procedure scheme. For the 55 flavouring substances for which the production volumes are anticipated 
figures, the present evaluation will have to be reconsidered when actual production volumes become 
available.    
The conclusions of FGE.96 were published in the minutes of the 17th CEF Panel meeting of 23-25 
November 2010. Since, some of the FGEs included in FGE.96 have been revised. It has therefore been 
decided in November 2011 to publish FGE.96, including only the JECFA-evaluated substances from 
FGEs which have not yet been revised.  
1. Presentation of the substances in the JECFA Flavouring Group 
1.1. Description 
1.1.1. JECFA Status 
The 107 flavouring substances considered in the present FGE have all been evaluated by JECFA in the 
period 2000 (53rd meeting) to 2008 (69th meeting). They have been evaluated through the Procedure 
based on the MSDI approach where the MSDI figures have all been based on US production volumes 
as no production volumes were available for Europe.  
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1.1.2. EFSA Considerations 
As no EU production volumes were available for the 107 flavouring substances no EU MSDI could be 
calculated and accordingly these substances could not be considered using the Procedure. 
EU Production volume / anticipated production volumes have now been provided for the 107 
substances (reference). 
In Table 1.1 the distribution of the 107 JECFA-evaluated substances into the corresponding EFSA 
FGE (1st column) have been listed. For each substance the Procedure evaluation step on which the 
substance has been approved by JECFA has been indicated (6th column) as well as the US MSDI value 
on which the evaluation was based (5th column). Based on the newly submitted EU production 
volumes / anticipated production volumes (7th column) EU MSDI values have been calculated (8th 
column). Based on the EU MSDI values the Panel concluded that the 107 can be considered using the 
Procedure. The outcome of this evaluation (Procedure step) is shown in the 9th column. 
Table 1.1 Distribution of 88 JECFA-evaluated substances into their respective FGEs 
FGE 
FL-no 
JECFA-
no 
Register name Structclass 
US-
MSDI 
µg/cap/
d 
Evaluated by 
JECFA based 
on US-MSDI  
At step (6)(7) 
EU 
Production 
volumes 
(kg/year) 
EU-MSDI 
µg/cap/d 
Evaluated by 
EFSA based 
on EU-MSDI 
At step (6)(8) 
FGE.51 09.230 1094 Cyclohexyl butyrate I 0.1 A3: No (59
th) 7.313 0.89 A3: No1 
FGE.52 04.093 888 Butyl vanillyl ether II 0.1 A3: No (57
th) 11.33 1.4 A3: No1 
FGE.52 08.071 883 p-Anisic acid I 0.1 A3: No (57
th) 13.593 1.7 A3: No1 
FGE.52 08.076 908 2,4-Dihydroxybenzoic acid I 6 A3: No (57
th) 454 5.5 A3: No1 
FGE.52 08.092 882 3-Methoxybenzoic acid I 0.01 A3: No (57
th) 0.14 0.012 A3: No1 
FGE.52 09.145 874 p-Anisyl propionate I 5 A3: No (57
th) 3.463 0.42 A3: No1 
FGE.52 09.807 907 o-Tolyl salicylate I 30 A3: No (57
th) 2304 28 A3: No1 
FGE.52 16.075 892 Ethyl vanillin beta-D-glucopyranoside II 30 A3: No (57
th) 2304 28 A3: No1 
FGE.53 06.027 1005 4,5-Dimethyl-2-benzyl-1,3-dioxolan I 1 A3: No (59
th) 1.03 0.12 A3: No1 
FGE.53 09.702 1010 Propyl phenylacetate I 0.3 A3: No (59
th) 1.13 0.13 A3: No1 
FGE.53 09.783 1008 Methyl phenylacetate I 20 A3: No (59
th) 778.43 95 A3: No1 
FGE.53 16.041 1029 Sodium 2-(4-methoxyphenoxy)propionate III 6 A3: No (59
th) 0.13 0.012 A3: No1 
FGE.54 06.019 840 1-Benzyloxy-1-(2-methoxyethoxy)ethane I 1 B4: Yes (57
th) 104 1.2 B4: Yes1 
FGE.54 09.294 863 2-Methylbenzyl acetate I 3 A3: No (57
th) 204 2.4 A3: No1 
FGE.54 09.803 862 Propylene glycol dibenzoate I 14 A3: No (57
th) 1104 13 A3: No1 
FGE.54 09.812 861 Glyceryl tribenzoate I 49 A3: No (57
th) 3704 45 A3: No1 
FGE.56 02.224 1408 3-(1-Menthoxy)propane-1,2-diol I 789 A3: No (63
rd) 33.73 4.1 A3: No1 
FGE.56 02.246 1416 p-Menthane-3,8-diol I 18 A3: No (63
rd) 321.84 39 A3: No1 
FGE.56 02.254 1411 3-Menthoxy-2-methylpropane-1,2-diol I 500 A3: No (63
rd) 5004 61 A3: No1 
FGE.58 04.037 720 4-Ethoxyphenol I 0.4 A3: No (55
th) 34 0.37 A3: No1 
FGE.58 04.052 723 4-Ethyl-2,6-dimethoxyphenol I 1 A3: No (55
th) 114 1.3 A3: No1 
FGE.58 04.053 722 4-Methyl-2,6-dimethoxyphenol I 0.04 A3: No (55
th) 0.444 0.054 A3: No1 
FGE.58 04.056 724 2,6-Dimethoxy-4-propylphenol I 0.1 A3: No (55
th) 0.54 0.061 A3: No1 
FGE.58 09.036 699 p-Tolyl acetate I 70 A3: No (55
th) 0.393 0.047 A3: No1 
FGE.58 09.102 704 p-Tolyl dodecanoate I 0.3 A3: No (55
th) 24 0.24 A3: No1 
FGE.58 09.288 731 4-(4-Acetoxyphenyl)butan-2-one I 0.1 A3: No (55
th) 0.973 0.12 A3: No1 
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Table 1.1 Distribution of 88 JECFA-evaluated substances into their respective FGEs 
FGE 
FL-no 
JECFA-
no 
Register name Structclass 
US-
MSDI 
µg/cap/
d 
Evaluated by 
JECFA based 
on US-MSDI  
At step (6)(7) 
EU 
Production 
volumes 
(kg/year) 
EU-MSDI 
µg/cap/d 
Evaluated by 
EFSA based 
on EU-MSDI 
At step (6)(8) 
FGE.61 06.081 943 1-Ethoxy-1-(3-hexenyloxy)ethane I 0 A3: No (57
th) 37.693 4.6 A3: No1 
FGE.62 02.189 1283 Nona-3,6-dien-1-ol I 0.9 A3: No (61
st) 1.073 0.13 A3: No1 
FGE.62 02.243 1284 (E,Z)-3,6-Nonadien-1-ol I 0.9 A3: No (61
st) 54 0.61 A3: No1 
FGE.63 07.069 1121 Tetrahydro-pseudo-ionone II 0.01 A3: No (59
th) 0.14 0.012 A3: No1 
FGE.63 07.100 1119 5-Methylhex-5-en-2-one II 0.3 A3: No (59
th) 24 0.24 A3: No1 
FGE.63 09.658 1142 1-Methylbutyl butyrate I 1 A3: No (59
th) 3.823 0.47 A3: No1 
FGE.64 06.040 913 1,2,3-Tris([1'-ethoxy]-ethoxy)propane I 140 A3: No (57
th) 1 0.12 A3: No1 
FGE.64 08.004 930 Lactic acid I 47000 A4: Yes (57
th) 1562803 19000 No safety concern8 
FGE.64 09.443 939 Isopentyl pyruvate I 0 A3: No (57
th) 143 17 A3: No1 
FGE.64 09.552 914 3-Oxodecanoic acid glyceride III 270 A4: Yes (57
th) 429 52 A3: No2 
FGE.64 09.555 910 3-Oxohexanoic acid glyceride III 270 A4: Yes (57
th) 0.5 0.061 A3: No2 
FGE.64 09.557 916 3-Oxotetradecanoic acid glyceride III 270 A4: Yes (57
th) 0.1 0.012 A3: No2 
FGE.64 16.039 933 Potassium 2-(1'-ethoxy)ethoxypropanoate I 1400 A3: No (57
th) 100004 1200 A3: No1 
FGE.68 02.051 675 5-Phenylpentan-1-ol I 0.1 A3: No (55
th) 104 1.2 A3: No1 
FGE.68 05.094 680 3-(4-Isopropylphenyl)propionaldehyde I 0.1 A3: No (55
th) 0.14 0.012 A3: No1 
FGE.68 09.071 642 3-Phenylpropyl hexanoate I 0.4 A3: No (55
th) 24 0.24 A3: No1 
FGE.68 09.084 637 3-Phenylpropyl formate I 0.8 A3: No (55
th) 0.14 0.012 A3: No1 
FGE.68 09.746 643 Methyl 3-phenylpropionate I 3 A3: No (55
th) 14 0.12 A3: No1 
FGE.68 09.780 760 Cinnamyl benzoate I 1 A3: No (55
th) 104 1.2 A3: No1 
FGE.69 07.070 830 3-Benzylheptan-4-one II 1 A3: No (57
th) 0.413 0.05 A3: No1 
FGE.69 09.189 823 1-Phenylpropyl butyrate I 0.3 A3: No (57
th) 24 0.24 A3: No1 
FGE.69 09.200 816 1-Methyl-3-phenylpropyl acetate I 7 A3: No (57
th) 504 6.1 A3: No1 
FGE.69 09.501 835 Ethyl 2-acetyl-3-phenylpropionate I 0.4 A3: No (57
th) 34 0.37 A3: No1 
FGE.70 08.085 1176 Hexa-2,4-dienoic acid I 6 A3: No (57
th) 5004 61 No safety concern8 
FGE.70 09.371 1193 Ethyl deca-2,4,7-trienoate I 0.4 A3: No (61
st) 0.24 0.024 A3: No1 
FGE.70 09.639 1191 Methyl deca-2,4-dienoate I 1 A3: No (61
st) 0.84 0.097 A3: No1 
FGE.71 08.073 1372 Dec-2-enoic acid I 4 A3: No (63
rd) 0.14 0.012 A3: No1 
FGE.71 08.123 1373 trans-2-Heptenoic acid I 4 A3: No (63
rd) 394 4.7 A3: No1 
FGE.71 09.157 1352 Ethyl 2-nonynoate I 0.9 A3: No (63
rd) 94 1.1 A3: No1 
FGE.71 09.239 1358 Methyl 2-undecynoate I 0.04 A3: No (63
rd) 0.14 0.012 A3: No1 
FGE.73 02.141 986 
2-(6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-
yl)ethan-1-ol I 0.01 A3: No (59
th) 2704 33 A3: No1 
FGE.73 09.488 966 Ethyl cyclohexanepropionate I 0.1 A3: No (59
th) 14 0.12 A3: No1 
FGE.73 09.534 963 Ethyl cyclohexanecarboxylate I 0.1 A3: No (59
th) 24 0.24 A3: No1 
FGE.75 13.060 1447 Tetrahydrofurfuryl cinnamate III 0.01 A3: No (63
rd) 0.14 0.012 A3: No1 
FGE.76 15.002 1057 2-Methyl-5-methoxythiazole III 0.01 B4: Yes (59
th) 0.14 0.012 B4: Yes1 
FGE.76 15.008 1053 2-Thienyl disulfide III 0.07 B4: Yes (59
th) 0.54 0.061 B4: Yes1 
FGE.76 15.027 1042 2-Propionylthiazole II 0.2 B4: Yes (59
th) 0.463 0.056 B4: Yes1 
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Table 1.1 Distribution of 88 JECFA-evaluated substances into their respective FGEs 
FGE 
FL-no 
JECFA-
no 
Register name Structclass 
US-
MSDI 
µg/cap/
d 
Evaluated by 
JECFA based 
on US-MSDI  
At step (6)(7) 
EU 
Production 
volumes 
(kg/year) 
EU-MSDI 
µg/cap/d 
Evaluated by 
EFSA based 
on EU-MSDI 
At step (6)(8) 
FGE.77 14.045 1305 2-Acetyl-1-ethylpyrrole II 0.009 A3: No (63
rd) 1 0.12 B4: No2 
FGE.77 14.058 1311 2-Isobutylpyridine III 0.9 A3: No (63
rd) 0.053 0.0061 B4: Yes2 
FGE.77 14.059 1312 3-Isobutylpyridine II 0.07 A3: No (63
rd) 0.44 0.049 B4: Yes2 
FGE.77 14.164 1322 2-Propylpyridine II 0.9 A3: No (63
rd) 54 0.61 B4: Yes2 
FGE.79 17.001 1418 beta-Alanine I 13 A3: No (63
rd) 29243 360 A3: No1 
FGE.79 17.003 1438 l-Arginine I 57 
No safety 
concern (63rd) 8266
3 1000 No safety concern8 
FGE.79 17.015 1427 S-Methylmethioninesulponium chloride III
5 75 A3: No (63rd) 28583 350 B4: Yes1 
FGE.79 17.026 1439 l-Lysine I 57 
No safety 
concern (63rd) 8600 
3 1000 No safety concern8 
FGE.79 16.056 1435 Taurine I 217 A3: No (63
rd) 63173 770 A3: No1 
FGE.80 10.050 1161 
Hexahydro-3,6-dimethyl-2(3H)-
benzofuranone III 12 A3: No (61
st) 664 8.0 A3: No1 
FGE.80 10.061 1159 
cis-5-Hexenyldihydro-5-methylfuran-
2(3H)-one I 13 A3: No (61
st) 8294 100 A3: No1 
FGE.80 10.069 1158 3-Methyl gamma-decalactone I 5 A3: No (61
st) 374 4.5 A3: No1 
FGE.80 10.070 1157 4-Methyl-5-hexen-1,4-olide I 3 A3: No (61
st) 184 2.2 A3: No1 
FGE.80 10.072 1167 Dimethyl-3,6-benzo-2(3H)-furanone III 2 B4: Yes (61
st) 6.923 0.84 B4: Yes1 
FGE.80 13.161 1166 Octahydrocoumarin III 0.07 A3: No (61
st) 10.33 1.3 A3: No1 
FGE.83 13.027 1485 2-Pentyl-5 or 6-keto-1,4-dioxane III 0.2 A3: No (65
th) 14 0.12 A3: No1 
FGE.83 13.028 1484 2-Butyl-5 or 6-keto-1,4-dioxane III 0.5 A3: No (65
th) 3.54 0.43 A3: No1 
FGE.84 09.561 1538 Hex-3(cis)-enyl anthranilate I 53 A3: No (65
th) 0.13 0.012 A3: No1 
FGE.84 09.722 1541 Cyclohexyl anthranilate I 0.007 A3: No (65
th) 0.064 0.0073 A3: No1 
FGE.84 09.801 1544 2-Naphthyl anthranilate I 2 A3: No (65
th) 114 1.3 A3: No1 
FGE.85 14.014 1566 
5,7-Dihydro-2-methylthieno(3,4-
d)pyrimidine III 0.4 B4: Yes (65
th) 0.13 0.012 B4: Yes1 
FGE.85 14.029 1568 1-Phenyl-(3 or 5)-propylpyrazole III 0.2 B4: Yes (65
th) 1.44 0.17 B4: Yes1 
FGE.85 14.070 1565 4-Acetyl-2-methylpyrimidine II 0.01 B4: Yes (65
th) 0.094 0.011 B4: Yes1 
FGE.87 09.153 1392 Bornyl valerate I 5 A3: No (63
rd) 304 3.7 A3: No1 
FGE.87 09.319 1412 Bornyl butyrate I 9 A3: No (63
rd) 504 6.1 A3: No1 
 
1 EFSA agrees with the way JECFA has applied the Procedure when based on the US MSDI. 
2 EFSA does not agree with the JECFA application of the Procedure but concluded the substance at another Procedure step (see text). 
3 Newly provided EU production volume. EFFA survey conduction in 2004, the EU MSDI has been calculated using the EU population size 
in this year. 
4 Newly provided EU production volume. EFFA anticipated production volumes 2010, the EU MSDI has been calculated using the EU 
population size in this year. 
5 EFSA has allocated this substance to structural class I (see text). 
6 For the Procedure steps – see Annex I. 
7 No of JECFA meeting evaluated at. 
8 Not evaluated through the Procedure for various reasons (see text). 
1.2. Isomers 
1.2.1. JECFA Status 
Of the 88 JECFA-evaluated substances 36 [FL-no: 02.141, 02.224, 02.246, 02.254, 06.019, 06.027, 
06.040, 06.081, 07.069, 07.070, 08.004, 09.153, 09.189, 09.200, 09.319, 09.501, 09.552, 09,555, 
09.557, 09.658, 09.803, 10.050, 10.061, 10.069, 10.070, 10.072, 13.027, 13.028, 13.060, 13.161, 
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16.039, 16.041, 16.075, 17.003, 17.015, 17.026] possess one or more chiral centres and 12 [FL-no: 
02.189, 02.243, 06.081, 08.073, 08.085, 08.123, 09.371, 09.561, 09.639, 09.780, 10.061 and 13.060] 
can exist as geometric isomers due to one or more double-bonds. Furthermore, six substances are 
mixtures of structural isomers. 
1.2.2. EFSA Considerations 
For one substance [FL-no: 06.040], in the present FGE.96, the stereoisomeric composition has to be 
specified. For seven of the stereoisomeric substances, the Industry (EFFA, 2010a) has informed that 
the commercial products are mixtures of stereoisomers, but no information on the ratio of the 
stereoisomers in the cases of mixtures has been given [FL-no: 08.073, 09.371, 09.780, 10.050, 13.060, 
13.161 and 16.039]. The composition of stereoisomeric mixtures has to be specified.  
1.3. Specifications 
1.3.1. JECFA Status 
The JECFA specifications are available for all substances in the present FGE. 
1.3.2. EFSA Considerations 
For one of the JECFA-evaluated substances the specifications are incomplete, as the solubility in 
water is missing for [FL-no: 09.807]. 
2. Intake Estimations 
2.1. JECFA Status 
By February/April 2010 Industry provided production volumes for these 107 substances. For 37 of the 
substances the provided production figure origins from the EFFA European survey conducted in 2004, 
for 64 of the provided production volumes the figure is anticipated (see Table 1.1). 
2.2. EFSA Considerations 
Based on these newly provided (anticipated) production figures MSDI for EU have been calculated 
(see Table 1.1). 
3. Application of the Procedure 
3.1. EFSA Considerations to the application of the Procedure as performed by JECFA in 
FGE.51, 52, 53, 54, 56, 58, 61, 62, 63, 64, 68, 69, 70, 71, 73, 76, 77, 79, 80, 83, 84, 85 and 
87. 
3.1.1. FGE.51 Alicyclic ketones and secondary alcohols and related esters (EFSA, 2008aj) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902162890.htm  
“The Panel agrees with the application of the Procedure as performed by the JECFA for the 13 
substances in the group of alicyclic ketones, secondary alcohols and related esters.  
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However, for one substance [FL-no: 09.230] no European production figure was available and 
consequently no European exposure estimates could be calculated. Accordingly, the safety in use 
could not be assessed using the Procedure for the substance”. 
3.1.1.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volume for [FL-no: 09.230] the MSDI is 0.89 
microgram/capita/day, which is below the threshold for a structural class I substance of 1800 
microgram/person/day.  
The Panel concluded at step A3 that [FL-no: 09.230] would be of no safety concern at the estimated 
level of intake based on the MSDI approach. 
3.1.2. FGE.52 Hydroxy- and alkoxy-substituted benzyl derivatives (EFSA, 2008y) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178692189524.htm  
“The Panel agrees with the application of the Procedure as performed by the JECFA at its 57th meeting 
(JECFA, 2002a) for 43 of the 44 substances in the group of hydroxy- and alkoxy-substituted benzyl 
derivatives. 
More recent studies on butyl 4-hydroxybenzoate [FL-no: 09.754] considered in the EFSA Opinion on 
methyl, ethyl and propyl 4-hydroxybenzoates, evaluated as food additives, have demonstrated that in 
juvenile rats given dietary doses of approximately 10, 100 or 1000 mg/kg body weight (bw) per day 
for eight weeks, effects were observed on male reproductive organs, sperm parameters or sex 
hormones at all doses (EFSA, 2004b; JECFA, 2007b). In juvenile mice given dietary doses of butyl 4-
hydroxybenzoate of 15-1500 mg/kg bw per day for ten weeks, effects on sperm counts and serum 
concentrations of testosterone were observed (JECFA, 2007b). As no NOAEL could be demonstrated 
for these effects on male reproductive parameters in rodents the Panel concluded that additional data 
would be required before butyl 4-hydroxybenzoate [FL-no: 09.754] can be evaluated as a flavouring 
substance using the Procedure”. 
For seven substances [FL-no: 04.093, 08.071, 08.076, 08.092, 09.145, 09.807 and 16.075] the 
evaluation could not be finalised due to missing EU production volumes. 
3.1.2.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the seven JECFA-evaluated substances 
[FL-no: 04.093, 08.071, 08.076, 08.092, 09.145, 09.807 and 16.075] the MSDIs range from 0.012 to 
28 microgram/capita/day, which are all below the threshold for their respective structural class.  
For all seven substances [FL-no: 04.093, 08.071, 08.076, 08.092, 09.145, 09.807 and 16.075], the 
Panel concluded at step A3 that these substances would be of no safety concern at their estimated level 
of intake based on the MSDI approach.  
3.1.3. FGE.53Rev1 Phenethyl alcohol, aldehyde, acid and related acetals and esters (EFSA, 
2009aq) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902882405.htm 
“The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
all the 42 substances in the group of phenylethyl alcohol, aldehyde, acid and related acetals and esters 
and related substances.  
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However, for four substances [FL-no: 06.027, 09.702, 09.783 and 16.041] no European production 
figures were available and consequently no European exposure estimate could be calculated. 
Accordingly, the safety in use in Europe could not be assessed using the Procedure for these four 
substances”. 
3.1.3.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the four JECFA-evaluated substances [FL-
no: 06.027, 09.702, 09.783 and 16.041] the MSDIs range from 0.012 to 95 microgram/capita/day, 
which are all below the threshold for their respective structural class.  
For all four substances [FL-no: 06.027, 09.702, 09.783 and 16.041], the Panel concluded at step A3 
that these substances would be of no safety concern at their estimated level of intake based on the 
MSDI approach.  
3.1.4. FGE.54Rev1 Benzyl derivatives (EFSA, 2009af) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902524149.htm 
“The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
all the 37 substances in the group of benzyl derivatives performed. 
However, for four substances [FL-no: 06.019, 09.294, 09.803 and 09.812] no European production 
volumes were available and consequently no European exposure estimate could be calculated. 
Accordingly, the safety in use in Europe could not be assessed using the Procedure for these four 
substances.” 
3.1.4.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the four JECFA-evaluated substances [FL-
no: 06.019, 09.294, 09.803 and 09.812] the MSDIs range from 1.2 to 45 microgram/capita/day, which 
are below the threshold for their structural class.  
For three substances [FL-no: 09.294, 09.803 and 09.812], the Panel concluded at step A3 that these 
substances would be of no safety concern at their estimated level of intake based on the MSDI 
approach.  
For [FL-no: 06.019], which was evaluated via the B-side of the Procedure, an NOAEL for a 
structurally related substance was not available. However, the Panel noted that upon ingestion, this 
substance will be hydrolysed to yield benzyl alcohol [FL-no: 02.010], acetaldehyde [FL-no: 05.001] 
and methoxyethanol (not in register). Benzyl alcohol [FL-no: 02.010] and acetaldehyde [FL-no: 
05.001] were considered of no safety concern by EFSA in FGE.54Rev1 and by the JECFA in 1999.  
When ingested at the level of the MSDI (1.2 microgram/capita/day), substance [FL-no: 06.019] will 
release 0.43 microgram/capita/day of methoxyethanol. For this substance a NOAEL of 6 mg/kg 
bw/day has been identified in a multi-generation study (Gulati et al., 1990a; Gulati et al., 1990b), as 
cited by JECFA 2002a). When the estimated exposure to methoxyethanol released from [FL-no: 
06.019] is compared to this NOAEL an adequate margin of safety of 8.3 × 105 can be calculated. 
Therefore the Panel concluded that this substance would be of no safety concern at the estimated level 
of intake based on the MSDI approach at step B4 of the Procedure. 
3.1.5. FGE.56 Monocyclic secondary alcohols, ketones and related esters (EFSA, 2009i) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902255809.htm 
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“The Panel agrees with the application of the Procedure as performed by the JECFA for four out of the 
six monocyclic secondary alcohols, ketones and related esters [FL-no: 02.224, 02.246, 02.254 and 
09.521]. However, for three substances [FL-no: 02.224, 02.246 and 02.254] no European production 
figures were available and consequently no European exposure estimates could be calculated. 
Accordingly, the safety in use could not be assessed using the Procedure for these three substances. 
For [FL-no: 07.110 and 07.111] the Panel concluded in line with the conclusion on cyclotetradecanone 
[FL-no: 07.207] evaluated in FGE.09Rev1, that the substances could not be anticipated to be 
metabolised to innocuous products and should therefore be evaluated via the B-side of the EFSA 
Procedure. As no adequate NOAELs were available for [FL-no: 07.110 and 07.111], additional data 
were required for these substances.” 
3.1.5.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the three JECFA-evaluated substances [FL-
no: 02.224, 02.246 and 02.254] the MSDIs range from 4.1 to 61 microgram/capita/day, which are 
below the threshold for their structural class.  
For three substances [FL-no: 02.224, 02.246 and 02.254], the Panel concluded at step A3 that these 
substances would be of no safety concern at their estimated level of intake based on the MSDI 
approach.  
3.1.6. FGE.58 Phenol derivatives (EFSA, 2008ab) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178710472028.htm 
The Panel agrees with the application of the Procedure as performed by the JECFA for 43 of the 44 
substances in the group of phenol derivatives. 
The Panel has transferred one substance [FL-no: 07.046], which contain an alpha,beta-unsaturated 
ketone, to subgroup 3.2 of FGE.19, for further evaluation of possible genotoxic potential. 
For seven substances [FL-no: 04.037, 04.052, 04.053, 04.056, 09.036, 09.102 and 09.288] no 
European production figures were available and consequently no European exposure estimate could be 
calculated. Accordingly, the safety in use in Europe could not be assessed using the Procedure for 
these substances. 
3.1.6.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the seven JECFA-evaluated substances 
[FL-no: 04.037, 04.052, 04.053, 04.056, 09.036, 09.102 and 09.288] the MSDIs range from 0.047 to 
1.3 microgram/capita/day, which are below the threshold for their structural class.  
For all seven substances the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated level of intake based on the MSDI approach.  
3.1.7. FGE.61Rev1 Aliphatic acyclic acetals (EFSA, 2009aj) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902722375.htm 
“The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
all nine substances in the group of aliphatic acyclic acetals. 
However, for one substance [FL-no: 06.081] no European production figure was available and 
consequently no European exposure estimate could be calculated. Accordingly, the safety in use in 
Europe could not be assessed using the Procedure for this substance.“ 
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3.1.7.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the [FL-no: 06.081] the MSDI is 4.6 
microgram/capita/day, which is below the threshold for a structural class I substance.  
For [FL-no: 06.081] the Panel concluded at step A3 that this substance would be of no safety concern 
at the estimated level of intake based on the MSDI approach.  
3.1.8. FGE.62Rev1 Linear and branched-chain aliphatic unsaturated, unconjugated alcohols, 
aldehydes, acids, and related esters (EFSA, 2008aq) 
http://www.efsa.europa.eu/en/scdocs/scdoc/1407.htm 
“The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
the 22 substances in the group of linear and branched-chain aliphatic unsaturated, unconjugated 
alcohols, aldehydes, acids, and related esters. The Panel considered the study by Cox et al., 1978 on 
ethyl-2-methyl-3,4-pentadienoate [FL-no: 09.540] valid to provide a NOAEL and agree with JECFA 
that the decrease in body weight seen in female rats was not considered relevant. 
For two substances [FL-no: 02.189 and 02.243] no European production figures were available and 
consequently no European exposure estimates could be calculated. Accordingly, the safety in use in 
Europe could not be assessed using the Procedure for these substances”. 
3.1.8.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the two JECFA-evaluated substances [FL-
no: 02.189 and 02.243] the MSDIs are 0.13 and 0.61 microgram/capita/day, respectively, which are 
below the threshold for a structural class I substance.  
For the two substances  the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated level of intake based on the MSDI approach.  
3.1.9. FGE.63 Aliphatic secondary alcohols, ketones and related esters (EFSA, 2008ae) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178706503680.htm 
 “The Panel agrees with the application of the Procedure as performed by the JECFA for the 13 
substances in the group of aliphatic secondary alcohols, ketones and related esters.“ 
For three substances [FL-no: 07.069, 07.100 and 09.658] no European production figures were 
available and consequently no European exposure estimates could be calculated. Accordingly, the 
safety in use in Europe could not be assessed using the Procedure for these substances. 
3.1.9.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the three JECFA-evaluated substances [FL-
no: 07.069, 07.100 and 09.658] the MSDIs range from 0.012 to 0.47 microgram/capita/day, which are 
all below the threshold for their respective structural class.  
For the three substances  the Panel concluded at step A3 that these three substances would be of no 
safety concern at their estimated level of intake based on the MSDI approach.  
3.1.10. FGE.64 Aliphatic acyclic diols, triols, and related substances (EFSA, 2009p) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902322349.htm 
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“The Panel agrees with the application of the Procedure as performed by the JECFA for the 25 
aliphatic acyclic diols, triols and related substances. However, for seven substances [FL-no: 06.040, 
08.004, 09.443, 09.552, 09.555, 09.557 and 16.039] no European production figures were available 
and consequently no European exposure estimate could be calculated. Accordingly the safety in use 
could not be assessed using the Procedure for these seven substances“. 
3.1.10.1. EFSA considerations based on new information on production volumes  
Based on newly submitted EU production volumes for the seven JECFA-evaluated substances [FL-no: 
06.040, 08.004, 09.443, 09.552, 09.555, 09.557 and 16.039], for which EU production volumes were 
missing, the MSDIs range from 0.012 to 19000 microgram/capita/day. The MSDI for lactic acid [FL-
no: 08.004] is 19000 microgram/capita/day, which is above the threshold of toxicological concern for 
the structural class for lactic acid of 1800 microgram/person/day. However, the human exposure of the 
candidate substance lactic acid [FL-no: 08.004] through food is orders of magnitude higher than the 
anticipated levels of exposure from the use of the flavouring substances. Therefore this substance is 
not taken through the Procedure. In addition, in 1973 JECFA derived an ADI “not limited” for lactate 
and several salts (JECFA, 1974d). In 1991, this view was also supported by the SCF (SCF, 1991); 
ADI “not specified” and later iterated in the evaluation of lactate and sodium lactate for poultry 
carcass treatment (EFSA, 2006l). Therefore, the Panel concluded that the substance was not of safety 
concern at the estimated level of intake as flavouring substance. 
For [FL-no: 06.040, 09.443 and 16.039] the MSDI is below the threshold of 1800 
microgram/person/day for a structural class I substance. Thus, for the three substances the Panel 
concluded at step A3 that these substances would be of no safety concern at the estimated level of 
intake based on the MSDI approach. 
For [FL-no: 09.552, 09.555 and 09.557] from structural class III the JECFA concluded these 
substances at step A4: the US MSDI were above the threshold of structural class III of 90 
microgram/person/day, but the substances are endogenous. As the EU MSDIs are below the threshold 
of the structural class for all three substances, the Panel could conclude the three substances at step 
A3.  
Thus the Panel concluded that all seven substances would be of no safety concern at their estimated 
level of intake based on the MSDI approach. 
3.1.11. FGE.68 Cinnamyl alcohol and related flavouring (EFSA, 2009ak) 
http://www.efsa.europa.eu/en/efsajournal/pub/1032.htm 
“The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
all 54 substances in the group of cinnamyl alcohol and related substances.  
However, the structural class have, based on EFSA considerations, been changed for the following 
flavouring substances: 
•  [FL-no: 06.013, 09.026 and 09.090 and 09.468] from structural class I to class II, 
•  [FL-no: 02.051] from structural class II to class I, 
•  [FL-no: 06.014] from structural class II to class III. 
These changes in structural classes do not give rise to change in the outcome of the application of the 
Procedure. 
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For six substances [FL-no: 02.051, 05.094, 09.071, 09.084, 09.746 and 09.780] no European 
production figures were available and consequently no European exposure estimates could be 
calculated. Accordingly, the safety in use in Europe could not be assessed using the Procedure for 
these six substances.“ 
3.1.11.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the six JECFA-evaluated substances [FL-
no: 02.051, 05.094, 09.071, 09.084, 09.746 and 09.780] the MSDIs range from 0.012 to 1.2 
microgram/capita/day, which are all below the threshold for their respective structural class.  
For all six substances the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated levels of intake based on the MSDI approach.  
3.1.12. FGE.69 Aromatic substituted secondary alcohols, ketones, and related esters (EFSA, 
2008am) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902172504.htm 
“The Panel agrees with the application of the Procedure as performed by the JECFA for all the 33 
substances in the group of aromatic substituted secondary alcohols, ketones and related esters.  
However, for four substances [FL-no: 07.070, 09.189, 09.200 and 09.501] no European production 
figures are available and consequently no European exposure estimates could be calculated. 
Accordingly, the safety in use in Europe could not be assessed using the Procedure for these four 
substances.” 
3.1.12.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the four JECFA-evaluated substances [FL-
no: 07.070, 09.189, 09.200 and 09.501] the MSDIs range from 0.05 to 6.1 microgram/capita/day, 
which are all below the threshold for their respective structural class I and II.  
For all four substances the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated level of intake based on the MSDI approach.  
3.1.13. FGE.70 Aliphatic, alicyclic, linear, alpha,beta-unsaturated, di- and tri-enals and related 
alcohols, acids and esters (EFSA, 2009at) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902866033.htm 
“Following hydrolysis of the esters in the gastrointestinal tract, the resulting carboxylic acids will 
participate in normal fatty acid metabolism including beta-oxidation and citric acid cycle, which 
finally leads to the total oxidation of these substances as described for the mono-unsaturated, shorter 
chain carboxylic acids evaluated in FGE.05 Revision 1 (Annex III of FGE.05Rev.1 (EFSA, 2008j). 
The Panel therefore agrees with the conclusion of the JECFA, that the substances in this FGE will be 
metabolised to innocuous products and can be evaluated via the A-side of the Procedure.  
The Panel agrees with the way that the application of the Procedure has been performed by the JECFA 
for all seven substances. However, for three substances [FL-no: 08.085, 09.371 and 09.639] no 
European production figures were available and consequently no European exposure estimates could 
be calculated. Accordingly, the safety in use in Europe could not be assessed using the Procedure for 
these three substances.  
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The Panel notes that one of these substances hexa-2,4-dienoic acid [FL-no: 08.085] (synonyms: 2,4-
hexadienoic acid and sorbic acid), together with its calcium, sodium and potassium salts, has been 
allocated a group ADI of 25 mg/kg body weight (expressed as sorbate) by the JECFA (JECFA, 
1986a).” 
3.1.13.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the three JECFA-evaluated substances [FL-
no: 08.085, 09.371 and 09.639] the MSDIs range from 0.024 to 61 microgram/capita/day.  For the two 
substances [FL-no: 09.371 and 09.639] the MSDI values are below the threshold for their structural 
class.  
For the remaining substance [FL-no: 08.085], the MSDI (61 microgram/capita/day; 1 microgram/kg 
bw/day) is also below the threshold for its structural class. However, as an ADI of 25 mg/kg bw/day 
(sorbic acid) has been derived by the JECFA (JECFA, 1986a) and by the EU-SCF in 1996 (EC, 
1996b), the Panel considers it more appropriate to evaluate the exposure to this substance when used 
as a flavouring substance with this ADI. The ADI is not exceeded.  
Thus for these three substances [FL-no: 08.085, 09.371 and 09.639] the Panel concluded that these 
substances would be of no safety concern at their estimated level of intake based on the MSDI 
approach. For two of these substances, this decision was reached at step A3 of the Procedure. For the 
third one, this decision was reached by comparison of the exposure estimate (MSDI) with the ADI 
available for this substance.  
3.1.14. FGE.71 Aliphatic, linear, alpha,beta-unsaturated carboxylic acids and related esters (EFSA, 
2010a) 
http://www.efsa.europa.eu/en/scdocs/scdoc/1401.htm 
“The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
all nine substances in the group of aliphatic alpha,beta-unsaturated aldehydes, acids and related 
alcohols, acetals and esters. 
However, for four substances, [FL-no: 08.073, 08.123, 09.157 and 09.239] no European production 
volumes were available and consequently no European exposure estimates could be calculated. 
Accordingly, the safety in use in Europe could not be assessed using the Procedure for these four 
substances.” 
3.1.14.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the four JECFA-evaluated substances [FL-
no: 08.073, 08.123, 09.157 and 09.239] the MSDIs range from 0.012 to 4.7 microgram/capita/day, 
which are below the threshold for their structural class.  
For the four substances the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated level of intake based on the MSDI approach.  
3.1.15. FGE.73 Alicyclic primary alcohols, aldehydes, acids and related esters (EFSA, 2008an) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902172436.htm 
“The Panel agrees with the application of the Procedure as performed by the JECFA for the 15 
substances in the group of alicyclic primary alcohols, aldehydes, acids and related esters.  
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The Panel noted that one substance [FL-no: 05.123] has a terminal double bond. Although 
theoretically, the double bond may be oxidised to give reactive epoxides, it is expected that for 
this substance, the metabolism via this pathway is negligible. The terminal double bond is present 
in a molecule that has aldehyde function at the end distal from the double bond. The aldehyde 
function is expected to be readily attacked by oxidation processes, ultimately yielding unsaturated 
carboxylic acids. Biochemical attack of these carboxylic acids via e.g. beta-oxidation or 
conjugation with glucuronic acid is expected to be much more efficient and rapid than microsomal 
oxidation.  
However, for three substances [FL-no: 02.141, 09.488 and 09.534] no European production 
figures were available and consequently no European exposure estimates could be calculated. 
Accordingly, the safety in use could not be assessed using the Procedure for these three 
substances.” 
3.1.15.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the three JECFA-evaluated substances [FL-
no: 02.141, 09.488 and 09.534] the MSDIs range from 0.12 to 33 microgram/capita/day, which are 
below the threshold for their structural class.  
For the three substances the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated level of intake based on the MSDI approach.  
3.1.16. FGE.75 Tetrahydrofuran and furanone derivatives (EFSA, 2008aw) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902219579.htm 
“The JECFA concluded all the 11 tetrahydrofuran derivatives at step A3. The Panel agrees with the 
application of the Procedure as performed by the JECFA for 10 of the 11 substances. For the 
remaining substance [FL-no: 13.097] the Panel did not find that the substance could be metabolized to 
innocuous products and should accordingly be evaluated via the B-side of the Procedure scheme. A 
NOAEL could not be identified for the substance or for structurally related substances and 
accordingly, additional data are required for this substance. 
For one substance [FL-no: 13.060] no European production figures were available and consequently 
no European exposure estimate could be calculated. Accordingly, the safety in use in Europe could not 
be assessed using the Procedure for this substance.” 
3.1.16.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volume for the JECFA-evaluated substance [FL-no: 
13.060] the MSDI is 0.012 microgram/capita/day, which is below the threshold for a structural class 
III substance of 90 microgram/person/day.  
For [FL-no: 13.060] the Panel concluded at step A3 that this substance would be of no safety concern 
at the estimated level of intake based on the MSDI approach.  
3.1.17. FGE.76 Sulfur-containing heterocyclic substances (EFSA, 2008ap) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902192133.htm 
“The Panel agrees with the application of the Procedure, as performed by the JECFA, for 20 of the 26 
substances in the group of sulphur-containing heterocyclic compounds. Four of the 26 substances 
evaluated by the JECFA, thiazole [FL-no: 15.028], 2-(sec-butyl)-4,5-dimethyl-3-thiazoline [FL-no: 
Flavouring Group Evaluation 96
 
 
21 EFSA Journal 2011; 9(12):1924 
15.029], 4,5-dimethyl-2-ethyl-3-thiazoline [FL-no: 15.030] and 4,5-dimethyl-2-isobutyl-3-thiazoline 
[FL-no: 15.032] were considered by the Panel to have genotoxic potential in vitro, and therefore the 
Panel concluded that the Procedure should not be applied to these four flavouring substances until 
adequate in vivo genotoxicity data become available. Additionally, the Panel noted the presence of a 
terminal conjugated double bond in the substances 2,4-dimethyl-5-vinylthiazole [FL-no: 15.005] and 
4-methyl-5-vinylthiazole [FL-no: 15.018], which raised concern for genotoxicity. The Panel 
concluded, contrary to the JECFA, that the Procedure should not be applied to these two substances 
either until genotoxicity data become available. 
For the three substances [FL-no: 15.014, 15.015 and 16.027], expected to be metabolised to innocuous 
products (A-side), the Panel agrees with the JECFA-evaluation.  
For 17 of the remaining 20 substances the Panel agreed with the JECFA that they cannot be expected 
to be metabolised to innocuous products. The 17 substances were allocated to one of the 10 structural 
subgroups identified in FGE.21 (for description and explanation, see FGE.21). Taking these 
substances through the Procedure, it can be estimated that the intakes (MSDI) are below the thresholds 
for their structural classes II and III, and as the JECFA concluded that adequate NOAELs provides a 
sufficient safety margin, these substances were concluded at step B4 in the Procedure to be of no 
safety concern by the JECFA. For 15 of these 17 substances, from the structural subgroups A-Ic 
(thiophenes with thiol-containing ring substituents [FL-no: 15.001 and 15.008]) and A-II (thiazoles 
[FL-no: 15.002, 15.011, 15.013, 15.017, 15.019, 15.020, 15.021, 15.022, 15.026, 15.027, 15.033 and 
15.035]), as summarized in Table 3.1, including benzothiazole [FL-no: 15.016] which is not supported 
by the substances in FGE.21, the Panel agrees with the JECFA conclusion that these substances are 
not expected to be of safety concern when used as flavouring substances. For the remaining two of the 
17 substances, both from the structural subgroup B-IV (dithiazines [FL-no: 15.109 and 15.113]), the 
Panel concluded at step B4 in line with its previous evaluation of this subgroup in FGE.21 that there 
are no adequate NOAEL available to provide sufficient margins of safety from their use as flavouring 
substances and that additional toxicity data are needed. 
However, for eight substances [FL-no: 15.002, 15.005, 15.008, 15.027, 15.029, 15.030, 15.109 and 
15.113] no European production figures were available and consequently no European exposure 
estimates could be calculated. Accordingly, the safety in use in Europe could not be assessed using the 
Procedure for these eight substances.” 
3.1.17.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for three of the eight JECFA-evaluated 
substances [FL-no: 15.002, 15.008 and 15.027], for which EU production volumes were missing, the 
MSDIs range from 0.012 to 0.061 microgram/capita/day, which are all below the threshold for their 
respective structural class II and III. For the remaining five substances no production volume has been 
submitted. 
All three substances were evaluated via the B-side of the Procedure. 
For the substance 2-methyl-5-methoxythiazole [FL-no: 15.002], an NOAEL of 8.6 mg/kg bw/day was 
identified from a 90-day toxicity study (Posternak et al., 1975). Comparison of the exposure estimate 
(MSDI) of 0.012 microgram/capital/day for Europe with this NOAEL provides an adequate margin of 
safety of 4.3 × 107. 
For the substance 2-thienyl disulphide [FL-no: 15.008], an NOAEL of 0.29 mg/kg bw/day was 
identified from a 90-day toxicity study (Morgareidge and Oser, 1970g). Comparison of the exposure 
estimate (MSDI) of 0.061 microgram/capital/day for Europe with this NOAEL provides an adequate 
margin of safety of 2.9 × 105. 
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For the substance 2-propionylthiazole [FL-no: 15.027], no NOAEL was available for the substance 
itself, but a NOAEL of 50 mg/kg bw/day was identified from a 90-day toxicity study with the 
structurally related substance 2-acetylthiazole [FL-no: 15.020] (Wheldon et al., 1970). Comparison of 
the exposure estimate (MSDI) of 0.056 microgram/capital/day for Europe with this NOAEL provides 
an adequate margin of safety of 5.4 × 107.  
Therefore the Panel concluded at step B4 of the Procedure that these three substances would be of no 
safety concern at their estimated levels of intake based on the MSDI approach. 
3.1.18. FGE.77 Pyridine, pyrrole and quinoline derivatives (EFSA, 2009q) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902297025.htm 
“The Panel agrees with the application of the Procedure as performed by the JECFA for five of the 22 
substances. Methyl nicotinate [FL-no: 14.071], indole [FL-no: 14.007] and 3-methylindole [FL-no: 
14.004] were evaluated on the A-side of the Procedure as they were anticipated to be metabolised to 
innocuous products. 1-Furfurylpyrrole [FL-no: 13.134] and 2-pyridine methanethiol [FL-no: 14.030] 
were the only two substances evaluated through the B-side of the Procedure as the substances were not 
anticipated to be metabolised to innocuous products by JECFA.  
For 6-methylquinoline [FL-no: 14.042], the Panel concluded, in line with the conclusions for 2- 
methylquinoline, 4-methylquinoline and 4-butylquinoline in FGE.24Rev1 [FL-no: 14.138, 14.002, 
14.094] (EFSA, 2008t), that this substance should not be evaluated using the Procedure until adequate 
in vivo genotoxicity data become available. 
For the remaining 16 substances the Panel, in contrast to the JECFA, did not anticipate that they will 
be metabolised to innocuous products due to concern with respect to N-oxidation of pyridines and for 
the pyrroles concerns about N-oxidation and epoxidation and accordingly concluded that they should 
be evaluated along the B-side.  
For pyrrole and the five pyrrole derivatives and for isoquinoline [FL-no: 14.041, 13.134, 14.045, 
14.046, 14.047, 14.068 and 14.001] NOAELs could not be derived as such or for structurally related 
substances. Accordingly, additional toxicological data are required for these seven substances (step 
B4). 
For 10 substances [FL-no: 14.038, 14.039, 14.058, 14.059, 14.060, 14.061, 14.065, 14.066, 14.072 
and 14.164] NOAELs could be derived to provide adequate margins of safety to the estimated level of 
intakes as flavouring substance (step B4).  
A 90-day oral feeding study in rats is available for 2-acetylpyridine [FL-no: 14.038]. The NOAEL 
derived is 37 mg/kg bw/day (Til and van der Meulen, 1971). The MSDI values for the 10 pyridine 
derivatives in this FGE are between 0.06 and 50 microgram/capita/day. The combined estimated daily 
per capita intake of the 10 pyridine derivatives evaluated through the B-side is 57 microgram 
corresponding to 0.95 microgram/kg bw/day. Thus, a margin of safety of approximately 39000 can be 
calculated using the NOAEL of 37 mg/kg bw/day. The 10 pyridine derivatives in this flavouring group 
evaluated through the B-side are accordingly not expected to be of safety concern at the estimated 
levels of intake. 
However, for four substances [FL-no: 14.045, 14.058, 14.059 and 14.164] no European production 
figures were available for use as flavouring substances and consequently no European exposure 
estimates could be calculated. Accordingly, the safety in use in Europe could not be assessed using the 
Procedure for these four substances.” 
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3.1.18.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes the four JECFA-evaluated substances [FL-no: 
14.045, 14.058, 14.059 and 14.164], for which EU production volumes were missing,  the MSDIs 
range from 0.0061 to 0.61 microgram/capita/day, which are all below the threshold for their respective 
structural class II and III.  
For three of the four substances, which were evaluated via the B-side of the Procedure, an adequate 
margin of safety could be calculated using the NOAEL of 37 mg/kg bw/day from the structurally 
related substance 2-acetylpyridine [FL-no: 14.038] (Til and van der Meulen, 1971). Comparison of the 
exposure estimates (MSDIs) for these three substances with this NOAEL provides adequate margins 
of safety ranging from 3.6 × 106 to 3.6 × 108. 
For [FL-no: 14.045] a NOAEL could not be derived as such or for structurally related substances. 
Accordingly, additional toxicological data are required for this substance. 
Therefore the Panel concluded that [FL-no: 14.058, 14.059 and 14.164] would be of no safety concern 
at step B4 of the Procedure at their estimated levels of intake based on the MSDI approach but for 
[FL-no: 14.045] additional toxicological data are required. 
3.1.19. FGE.79  Amino acids and related substances (EFSA, 2008bm) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902181544.htm 
“The Panel agrees with the evaluation as performed by the JECFA for the 19 substances in the group 
of amino acids and related substances. 
The Panel noted that amino acids may react with other food constituents upon heating. The reaction 
mixtures formed are commonly referred to as “process flavours” which have not been evaluated by the 
Panel. The present evaluation is therefore on the basis that the present flavouring substances are in an 
unchanged form when they are consumed, thus in food that is not intended to be heated. 
However, for five substances [FL-no: 16.056, 17.001, 17.003, 17.015 and 17.026] no European 
production figures were available for use as flavouring substances and consequently no European 
exposure estimates could be calculated. Accordingly, the safety in use in Europe could not be assessed 
using the Procedure for these five substances.” 
3.1.19.1. EFSA considerations based on new information on production volumes 
Based on the newly submitted EU production volumes for the five JECFA-evaluated substances [FL-
no: 16.056, 17.001, 17.003, 17.015 and 17.026], for which EU production volumes were missing, the 
estimated MSDIs range from 350 to 1000 microgram/capita/day. 
For two of these substances [FL-no: 17.001 and 16.056], from structural class I and evaluated via the 
A-side of the Procedure, the EU MSDI is below the threshold of concern for the structural class I. 
Therefore, these substances would not be expected to be of safety concern at step A3 of the Procedure 
when used as flavouring substances.  
For the substances [FL-no: 17.015], in addition to the newly submitted data on use, the Panel 
considered additional information of metabolism. From this information, the Panel can no longer agree 
with JECFA with respect to the way this substance was evaluated through the Procedure by JECFA. 
For [FL-no: 17.015] two metabolic options have been described in literature. It can act as a methyl 
donor in the formation of methionine from homocysteine, catalyzed by the enzyme betaine 
homocysteine methyltransferase, in which process ultimately two methionine molecules are formed. In 
the other metabolic route the substance is hydrolytically cleaved to yield dimethyl sulphide and 
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homoserine (Gessler et al., 1991). Since dimethyl sulphide was evaluated by the JECFA via the B-side 
of the Procedure (JECFA, 2000b) and since dimethyl sulphide [FL-no: 12.006] is a structural analogue 
of a number of substances evaluated in FGE.08 via the B-side of the Procedure, it would be consistent 
to evaluate [FL-no: 17.015] also via the B-side, rather than via the A-side. The methionine or 
homoserine formed in the metabolic processes mentioned above are endogenous substances which are 
important intermediates in protein and amino acid metabolism and not of toxicological concern, 
similar to other amino acids (Voet and Voet, 2004; Karlsson, 1963). The dimethyl sulphide could 
theoretically be formed to a maximum level of 1.8 μg/kg bw, if [FL-no: 17.015] were ingested at the 
level of its MSDI (350 μg per capita per day), assuming complete hydrolysis and no demethylation by 
methyl transferase. If the dimethyl sulphide thus formed is evaluated through the Procedure at step B4, 
this exposure estimate could be compared to a NOAEL of 250 mg/kg bw/day obtained in a 90-day 
study in rats (Butterworth et al., 1975b). From this comparison an adequate Margin of Safety of 1.4 × 
105 can be calculated. Based on these considerations, the use of [FL-no: 17.015] as a flavouring 
substance is not of safety concern at the estimated level of exposure.  
The two substances [FL-no: 17.003 and 17.026] are macronutrients and normal components of 
proteins. The human exposure through food is orders of magnitude higher than the anticipated level of 
exposure from their use as a flavouring substances. These two substances will not be evaluated using 
the Procedure. The Panel concluded that these two substances would not be of safety concern at the 
estimated level of exposure. 
3.1.20. FGE.80Rev1 Alicyclic, alicyclic-fused and aromatic-fused ring lactones (EFSA, 2009au) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902878576.htm 
“The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
all 13 substances in the group of alicyclic, alicyclic-fused and aromatic-fused ring lactones. 
However, for six of these 13 substances [FL-no: 10.050, 10.061, 10.069, 10.070, 10.072 and 13.161] 
no European production figure was available and consequently no European exposure estimate could 
be calculated. Accordingly, the safety in use in Europe could not be assessed using the Procedure for 
these substances.” 
3.1.20.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the six JECFA-evaluated substances [FL-
no: 10.050, 10.061, 10.069, 10.070, 10.072 and 13.161] the MSDIs range from 0.84 to 100 
microgram/capita/day, which are below the threshold for their respective structural class I and III.  
For five substances [FL-no: 10.050, 10.061, 10.069, 10.070 and 13.161], the Panel concluded at step 
A3 that these substances would be of no safety concern at their estimated level of intake based on the 
MSDI approach.  
Candidate substance [FL-no: 10.072] was evaluated via the B-side of the Procedure and as no NOAEL 
for the substance itself could be found, its assessment should rely on the NOAEL of 5.42 mg/kg 
bw/day for the structurally related substance 3-propylidenephthalide [FL-no: 10.005] as derived in a 
90-day study by Posternak et al. (Posternak et al., 1969). Based on this NOAEL and the estimated 
exposure (MSDI) for Europe, of 0.84 microgram/capita/day, an adequate margin of safety of 3.9 × 105 
can be calculated. Therefore the Panel concluded that this substance would be of no safety concern at 
the estimated level of intake based on the MSDI approach.  
3.1.21. FGE.83Rev1 Ethyl maltol and two 6-keto-1,4-dioxane derivatives (EFSA, 2010b) 
http://www.efsa.europa.eu/en/scdocs/scdoc/1409.htm 
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“The Panel agrees with the way the application of the Procedure has been performed by the JECFA for 
the three substances in the group of ethyl maltol and 5- or 6-keto-1,4-dioxane derivatives. 
However, for the two substances [FL-no: 13.027 and 13.028] no European production figures were 
available and consequently no European exposure estimates could be calculated. Accordingly, the 
safety in use in Europe could not be assessed using the Procedure for the substances.” 
3.1.21.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the two JECFA-evaluated substances [FL-
no: 13.027 and 13.028] the MSDIs are 0.12 to 0.43 microgram/capita/day, respectively, which are 
below the threshold for a structural class III substance.  
For the two substances the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated levels of intake based on the MSDI approach.  
3.1.22. FGE.84 Anthranilate derivatives (EFSA, 2008ao) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902168053.htm 
“The Panel agrees with the application of the Procedure as performed by the JECFA for 17 of the 18 
substances in the group of anthranilate derivatives.  
For methyl anthranilate [FL-no: 09.715] the estimated daily exposure for Europe from its use as a 
flavouring substance is 686 microgram per person, which is below the threshold of 1800 microgram 
per person for class I substances. Therefore, the evaluation of methyl anthranilate as a flavouring 
substance in Europe could be concluded to be of no safety concern already at step A3 of the Procedure 
scheme, while the JECFA concluded “no safety concern” for this substance at step A5 (based on the 
US MSDI of 3764 microgram/person/day).  
However, for three substances [FL-no: 09.561, 09.722 and 09.801] no European production figures 
were available and consequently no European exposure estimates could be calculated. Accordingly, 
the safety in use in Europe could not be assessed using the Procedure for these three substances.  
The Panel considered further the possible consequences of nitrosation after ingestion of the secondary 
and tertiary amine and secondary amide candidate substances according to the approach described in 
the Annex to the minutes of the 30th AFC Panel meeting, May 2008 (EFSA, 2008e). From these 
considerations, the Panel concluded that extremely large margins of exposure could be calculated (>> 
109) for nitrosated products possibly formed from amines used as flavouring substances in foods. Such 
large margins of exposure indicate that a risk of carcinogenicity resulting from such possible 
nitrosation products is virtually absent. 
The Panel also notes that this conclusion is not applicable for foods preserved with nitrites, because 
for such foods the conditions for nitrosation, either in the foods themselves or after consumption in the 
stomach, may differ substantially from the worst-case conditions on which the calculations in the 
above mentioned Annex were based.”  
3.1.22.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the three JECFA-evaluated substances [FL-
no: 09.561, 09.722 and 09.801] the MSDIs range from 0.0073 to 1.3 microgram/capita/day, which are 
below the threshold for their structural class.  
For all three substances the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated levels of intake based on the MSDI approach.  
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3.1.23. FGE.85 Miscellaneous nitrogen containing flavouring substances (EFSA, 2008af) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902092610.htm 
“The Panel agrees with the application of the Procedure as performed by the JECFA for the 16 
substances in the group of miscellaneous nitrogen-containing substances.  
However, for three substances [FL-no: 14.014, 14.029 and 14.070] no European production figures 
were available and consequently no European exposure estimates could be calculated. Accordingly, 
the safety in use could not be assessed using the Procedure for these three substances.” 
3.1.23.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the three JECFA-evaluated substances [FL-
no: 14.014, 14.029 and 14.070] the MSDIs range from 0.011 to 0.17 microgram/capita/day, which are 
below the threshold for their respective structural class.  
All three substances were evaluated via the B-side of the Procedure. 
For the substance 5,7-dihydro-2-methylthieno(3,4-d)pyrimidine [FL-no: 14.014], an NOAEL of 6.6 
mg/kg bw/day was identified from a 90-day toxicity study (Shellenberger, 1970g); as cited by the 
JECFA (JECFA, 2006d). Comparison of the exposure estimate (MSDI) of 0.012 
microgram/capital/day for Europe with this NOAEL provides an adequate margin of safety of 3.3 × 
107. 
For the substance 1-phenyl-(3- or 5)-propylpyrazole [FL-no: 14.029], an NOAEL of 25 mg/kg bw/day 
was identified from a 90-day toxicity study (Posternak et al., 1969). Comparison of the exposure 
estimate (MSDI) of 0.17 microgram/capital/day for Europe with this NOAEL provides an adequate 
margin of safety of 8.8 × 106. 
For the substance 4-acetyl-2-methylpyrimidine [FL-no: 14.070] an NOAEL of 1 mg/kg bw/day was 
identified from a 90-day toxicity study (Peano, 1981); as cited by JECFA (JECFA, 2006d). 
Comparison of the exposure estimate (MSDI) of 0.011 microgram/capital/day for Europe with this 
NOAEL provides an adequate margin of safety of 5.5 × 106.  
Therefore the Panel concluded at step B4 of the Procedure that these three substances would be of no 
safety concern at their estimated levels of intake based on the MSDI approach. 
3.1.24. FGE.87 Bicyclic secondary alcohols, ketones and related esters (EFSA, 2008az) 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902222183.htm 
“The Panel agrees with the application of the Procedure as performed by the JECFA for the 15 
bicyclic secondary alcohols, ketones and related esters. However, for two substances [FL-no: 09.153 
and 09.319] no European production figures were available and consequently no European exposure 
estimates could be calculated. Accordingly, the safety in use could not be assessed using the Procedure 
for these two substances.” 
3.1.24.1. EFSA considerations based on new information on production volumes  
Based on the newly submitted EU production volumes for the two JECFA-evaluated substances [FL-
no: 09.153 and 09.319] the MSDIs are 3.7 and 6.1 microgram/capita/day, which are below the 
threshold for a structural class I substance.  
For the two substances the Panel concluded at step A3 that these substances would be of no safety 
concern at their estimated level of intake based on the MSDI approach. 
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4. Conclusion 
The present FGE.96 concerns 88 JECFA-evaluated substances from different groups. These groups 
have been previously considered by EFSA in FGE.51, 52, 53, 54, 56, 58, 61, 62, 63, 64, 68, 69, 70, 
71, 73, 76, 77, 79, 80, 83, 84, 85 and 87. Common for all the 88 substances was that for none of them 
European production volumes were available at the time for the first consideration in the above-
mentioned FGEs. As a consequence, no MSDI could be calculated for EU and accordingly the 
substances could not be considered by EFSA using the Procedure. 
By February/April 2010 Industry provided production volumes for these substances. For 27 of the 
substances the provided production figure origins from the EFFA European survey conducted in 2004 
and for 55 of the provided production volumes, the figure is anticipated (EFFA, 2010c). For the 
remaining six substances it has not been stated if the figures are from an European survey or 
anticipated production volumes (see Table 1.1). Based on these newly provided (anticipated) 
production figures, MSDI values for EU have been calculated (see Table 1.1 and Table 2), and based 
on these MSDI values the substances have been re-considered by EFSA in the current FGE.96. For the 
flavouring substances for which the production volumes are anticipated figures, the present evaluation 
will have to be reconsidered when actual production volumes become available. 
In the FGEs mentioned above, genotoxicity of the substances considered in FGE.96 has already been 
addressed. For none of the substances a concern for genotoxicity was identified. 
Seventy-one of the 88 substances were considered to be of no concern at step A3 of the Procedure and 
12 substances were considered to be of no concern at step B4. Four substances were not evaluated 
through the Procedure. Two of these four are macronutrients [FL-no: 17.003 and 17.026] for which 
the Procedure is not applicable, and one [FL-no: 08.004] is a very common constituent of food, for 
which an ADI ”non-specified” has been derived in the past. For the fourth substance (sorbic acid [FL-
no: 08.085]), an ADI has been derived. Based on the estimated exposure on the basis of the MSDI 
approach the Panel concluded no safety concern for these four substances. For the remaining 
substance, 2-acetyl-1-ethylpyrrole [FL-no: 14.045], the Panel could not identify an appropriate 
NOAEL and accordingly additional data are required. 
For five substances [FL-no: 14.045, 14.058, 14.059, 14.164 and 17.015] the Panel concluded that 
these should be evaluated via the B-side of the Procedure, where JECFA evaluated these substances 
via the A-side. However, based on the data available, the Panel concluded that four substances were 
not of safety concern at step B4 of the Procedure. For the remaining substance, 2-acetyl-1-ethylpyrrole 
[FL-no: 14.045], as mentioned above, the Panel could not identify an appropriate NOAEL and 
accordingly additional data are required. For three substances [FL-no: 09.552, 09.555 and 09.557] the 
Panel concluded at step A3 (where the JECFA concluded at step A4) as the EU MSDI were below the 
threshold of concern for the structural class.  
In order to determine whether the conclusion for the 88 JECFA-evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity tests are available for 79 of the JECFA-
evaluated substances. For [FL-no: 15.008], the solubility in water is missing. Otherwise the 
specifications for this substance are appropriate. For eight stereoisomeric substances [FL-no: 06.040, 
08.073, 09.371, 09.780, 10.050, 16.039, 13.060 and 13.161], the stereoisomeric composition has to be 
specified further.  
Thus, for 79 of the 88 substances, the Panel concluded that they would be of no safety concern when 
used at their estimated levels of intake as flavouring substances based on the MSDI approach. For 
eight of the remaining nine substances, additional data on stereochemical composition are required to 
finalise their evaluation as material of commerce. For [FL-no: 14.045] additional toxicity data are 
required to finalise the evaluation. 
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The Panel noted that amino acids [FL-no: 16.056, 17.001, 17.003, 17.015 and 17.026] may react with 
other food constituents upon heating. The reaction mixtures formed are commonly referred to as 
“process flavours” which have not been evaluated by the Panel. The present evaluation is therefore on 
the basis that the present flavouring substances are in an unchanged form when they are consumed, 
thus in food that is not intended to be heated. 
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TABLE 1: SPECIFICATION SUMMARY  
Table 1: specifications summary for the JECFA-evaluated substances in the present group 
Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
02.051 
675 
5-Phenylpentan-1-ol 
OH  
3618 
674 
10521-91-2 
Liquid 
C11H16O 
164.25 
Insoluble 
Miscible 
155 (26 hPa) 
 
IR 
98 % 
1.514-1.521 
0.970-0.977 
 
 
02.141 
986 
2-(6,6-Dimethylbicyclo[3.1.1]hept-2-
en-2-yl)ethan-1-ol 
OH  
3938 
 
128-50-7 
Liquid 
C11H18O 
166.26 
Insoluble 
Miscible 
230 
 
IR NMR 
95 % 
1.490-1.500 
0.965-0.973 
 
Racemate (EFFA, 2010a). 
02.189 
1283 
Nona-3,6-dien-1-ol OH
(Z,Z)-isomer shown  
3885 
10289 
76649-25-7 
Liquid 
C9H16O 
140.23 
Slightly soluble 
Soluble 
70 (3 hPa) 
 
IR NMR 
97 % 
1.462-1.469 
0.863-0.871 
 
CASrn in Register does not 
specify stereoisomeric 
composition. According to 
JECFA: Min. Assay value is 
"97 %  Z,Z , 1 % E,Z 
isomer; 1 %  Z,E isomer; 0.5 
%  E,E isomer". 
Register name to be changed 
to (Z,Z)-3,6-nonadien-1-ol. 
02.224 
1408 
3-(1-Menthoxy)propane-1,2-diol 
O OH
OH
3784 
 
87061-04-9 
Liquid 
C13H26O3 
230.35 
Very slightly soluble 
Soluble 
121-125(0.3hPa) 
 
NMR 
99 % 
1.472-1.476 
0.989-0.999 
 
Racemate. 
 
 
02.243 
1284 
(E,Z)-3,6-Nonadien-1-ol OH  3884 
 
56805-23-3 
Liquid 
C9H16O 
140.23 
Slightly soluble 
Soluble 
73 (20 hPa) 
 
IR NMR 
92 % 
1.462-1.469 
0.863-0.871 
 
According to JECFA: Min. 
assay value is "92 %" and 
secondary component 
"(E,E)-3,6-nonadien-1-ol". 
02.246 
1416 
p-Menthane-3,8-diol 
OH
OH
4053 
 
42822-86-6 
Solid 
C10H20O2 
172.27 
Slightly soluble 
Soluble 
105 (0.05 hPa) 
34.5 
IR 
99 % 
 
0.976-0.982 
 
Racemate. 
 
 
02.254 
1411 
3-Menthoxy-2-methylpropane-1,2-
diol 
O OH
OH
3849 
 
195863-84-
4  
Liquid 
C14H28O5 
244.36 
Slightly soluble 
Soluble 
124 (0.53 hPa) 
 
NMR 
99% 
1.468-1.474 
0.978-0.984 
 
CASrn in Register refers to 
the (1R, 2S, 5S) isomer. 
Register name to be changed 
to (1R,2S,5S)-3-Menthoxy-
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
2-methylpropane-1,2-diol. 
04.037 
720 
4-Ethoxyphenol 
OHO
 
3695 
2258 
622-62-8 
Solid 
C8H10O2 
138.17 
Slightly soluble 
Moderately soluble 
246-247 
64 
IR 
95 % 
n.a. 
n.a. 
 
According to JECFA: 
Melting point is "64° 
(minimum)". 
04.052 
723 
4-Ethyl-2,6-dimethoxyphenol 
OH
O
O 3671 
11231 
14059-92-8 
Liquid 
C10H14O3 
182.22 
Insoluble 
Miscible 
106 (0.3 hPa) 
 
MS 
98 % 
1.536-1.537 
1.075-1.080 
 
 
04.053 
722 
4-Methyl-2,6-dimethoxyphenol 
OH
O
O 3704 
 
6638-05-7 
Solid 
C9H12O3 
168.19 
Insoluble 
Moderately soluble 
145-146 (16hPa) 
37-42 
IR 
97 % 
n.a. 
n.a. 
 
 
04.056 
724 
2,6-Dimethoxy-4-propylphenol 
OH
O
O 3729 
 
6766-82-1 
Liquid 
C11H16O3 
196.25 
Insoluble 
Miscible 
115 (0.5 hPa) 
 
IR NMR 
98 % 
1.529-1.530 
1.071-1.076 
 
 
04.093 
888 
Butyl vanillyl ether 
HO
O
O
 
3796 
 
82654-98-6 
Liquid 
C12H18O3 
210.27 
Insoluble 
Miscible 
241 
 
IR 
95 % 
1.511-1.521 
1.048-1.068 
 
 
05.094 
680 
3-(4-
Isopropylphenyl)propionaldehyde 
O
 
2957 
2261 
7775-00-0 
Liquid 
C12H16O 
176.26 
Insoluble 
Miscible 
270 
 
MS 
90 % 
1.503-1.508 
0.946-0.952 
 
Minimum 95 % combined o- 
and p-isomers (EFFA, 
2010a).  
06.019 
840 
1-Benzyloxy-1-(2-
methoxyethoxy)ethane 
O
O
O
 
2148 
523 
7492-39-9 
Liquid 
C12H18O3 
210.27 
Insoluble 
Miscible 
161-162 (13hPa) 
 
IR 
98 % 
1.479-1.489 
1.019-1.025 
 
Racemate. Min. assay value: 
98 % (sum of parent 
compound and starting 
materials).  The “starting 
materials” are 
methoxyethanol, 
acetaldehyde and benzyl 
alcohol which make up less 
than 10 % combined of the 
mixture under anhydrous 
conditions (EFFA, 2010a). 
06.027 
1005 
4,5-Dimethyl-2-benzyl-1,3-dioxolan 
O
O  
2875 
669 
5468-06-4 
Liquid 
C12H16O2 
192.26 
Insoluble 
Miscible 
118 (13 hPa) 
 
NMR 
93 % 
1.496-1.512 
1.030-1.040 
 
Racemate. Secondary 
component: butane-2,3-diol 
(2-3 %) (EFFA, 2010a). 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
06.040 
913 
1,2,3-Tris([1'-ethoxy]-
ethoxy)propane   6) 
O
O
O
O
O
O
3593 
11930 
67715-82-6 
Liquid 
C15H32O6 
308.42 
Insoluble 
Miscible 
117 (1.3 hPa) 
 
NMR 
97.5 % 
1.419-1.425 
0.952-0.958 
 
 
06.081 
943 
1-Ethoxy-1-(3-hexenyloxy)ethane O
O  
3775 
10034 
28069-74-1 
Liquid 
C10H20O2 
172.27 
Insoluble 
Miscible 
85 (9 hPa) 
 
IR 
97 % 
1.430-1.435 
0.846-0.856 
 
Register name to be changed 
to 1-Ethoxy-1-(3Z-
hexenyloxy)ethane. 
Racemate of 1-Ethoxy-1-
(3Z-hexenyloxy)ethane 
(EFFA, 2010a).   
07.069 
1121 
Tetrahydro-pseudo-ionone O
 
3059 
2053 
4433-36-7 
Liquid 
C13H24O 
196.33 
Insoluble 
Miscible 
234 
 
NMR 
95 % 
1.449-1.455 
0.865-0.875 
 
Racemate (EFFA, 2010a). 
07.070 
830 
3-Benzylheptan-4-one O 2146 
2140 
7492-37-7 
Liquid 
C14H20O 
204.31 
Insoluble 
Miscible 
158-160 (13hPa) 
 
IR 
99 % 
1.490-1.495 
0.931-0.937 
 
Racemate (EFFA, 2010a).  
07.100 
1119 
5-Methylhex-5-en-2-one O
 
3365 
11150 
3240-09-3 
Liquid 
C7H12O 
112.17 
Insoluble 
Miscible 
148-149 
 
NMR 
97 % 
1.428-1.433 
0.862-0.868 
 
 
08.004 
930 
Lactic acid OH
OH
O  
2611 
4 
598-82-3 
Liquid 
C3H6O3 
90.08 
Miscible 
Miscible 
122 (20 hPa) 
17 
IR 
95 % 
1.413-1.429 
1.200-1.209 
 
Racemate (EFFA, 2010a). 
According to JECFA: Min. 
Assay value is "95 by 
chemical analysis (acid/base 
titration)". 
08.071 
883 
p-Anisic acid 
O
OH
O 3945 
10077 
100-09-4 
Solid 
C8H8O3 
152.15 
Soluble 
Freely soluble 
275-280 
184 
IR 
98 % 
n.a. 
n.a. 
 
 
08.073 
1372 
Dec-2-enoic acid 
OH
O
(E)-isomer shown  
3913 
10087 
3913-85-7 
Liquid 
C10H18O2 
170.25 
n.a. 
Soluble 
161-162 (20hPa) 
 
IR NMR MS 
97 % 
1.456-1.466 
0.923-0.933 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
08.076 
908 
2,4-Dihydroxybenzoic acid 
HO
OH O
OH
 
3798 
 
89-86-1 
Solid 
C7H6O4 
154.12 
Soluble 
Soluble 
n.a. 
225 
IR 
97 % 
n.a. 
n.a. 
 
According to JECFA: 
Melting point is "225° 
(decomposes, rapid heating 
required)". 
08.085 
1176 
Hexa-2,4-dienoic acid 
OH
O
 
3921 
 
110-44-1 
Solid 
C6H8O2 
112.13 
Slightly soluble 
Soluble 
n.a. 
132-135 
IR NMR 
99 % 
n.a. 
n.a. 
 
JECFA evaluated (E,E)-2,4-
hexadienoic acid (CASrn as 
in Register). CASrn in 
Register refers to the (E,E)-
isomer. Register name to be 
changed to (E,E)-hexa-2,4-
dienoic acid. 
08.092 
882 
3-Methoxybenzoic acid 
O
OH
O 3944 
 
586-38-9 
Solid 
C8H8O3 
152.15 
Soluble 
Freely soluble 
170-172 
107-109 
IR 
98 % 
n.a. 
n.a. 
 
 
08.123 
1373 
trans-2-Heptenoic acid    
OH
O
 
3920 
 
10352-88-2 
Liquid 
C7H12O2 
128.18 
n.a. 
Soluble 
224-228 
 
IR NMR MS 
97 % 
1.447-1.157 
0.968-0.978 
 
CASrn in Register refers to 
(E)-isomer.  
09.036 
699 
p-Tolyl acetate 
O
O
 
3073 
226 
140-39-6 
Liquid 
C9H10O2 
150.18 
Slightly soluble 
Miscible 
208-212 
 
IR 
98 % 
1.499-1.503 
1.044-1.052 
 
 
09.071 
642 
3-Phenylpropyl hexanoate 
O
O
2896 
321 
6281-40-9 
Liquid 
C15H22O2 
234.34 
Insoluble 
Miscible 
292 
 
IR 
99 % 
1.482-1.488 
0.947-0.960 
 
 
09.084 
637 
3-Phenylpropyl formate 
OO
 
2895 
351 
104-64-3 
Liquid 
C10H12O2 
164.20 
Insoluble 
Miscible 
238 
 
MS 
97 % 
1.494-1.499 
1.012-1.019 
 
 
09.102 
704 
p-Tolyl dodecanoate O
O  
3076 
378 
10024-57-4 
Liquid 
C19H30O2 
290.45 
Insoluble 
 
208-210 (13hPa) 
 
NMR 
90 % 
1.494-1.500 
0.946-0.952 
 
Mixture of p-tolyl 
dodecanoate (min. 90 %),  
p-tolyl tetradecanoate (3-6 
%), p-tolyl decanoate (2-5 
%), p-tolyl 
hexadecanoate(1-2 %) 
(EFFA, 2010a). 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
09.145 
874 
p-Anisyl propionate 
O
O
O 2102 
426 
7549-33-9 
Liquid 
C11H14O3 
194.23 
Insoluble 
Miscible 
100-103(0.7hPa) 
 
IR 
97 % 
1.505-1.510 
1.070-1.086 
 
 
09.153 
1392 
Bornyl valerate 
O
_____
O
 
2164 
471 
7549-41-9 
Liquid 
C15H26O2 
238.37 
Insoluble 
Soluble 
136-137 (16hPa) 
 
NMR 
96 % 
1.459-1.465 
0.957-0.963 
 
Racemate (±) = DL-bornyl 
valerate (EFFA, 2010a). 
CASrn in Register refers to 
(1R,2S,4R)-stereoisomer. 
Register CASrn to be 
changed. 
09.157 
1352 
Ethyl 2-nonynoate O
O
 
2448 
480 
10031-92-2 
Liquid 
C11H18O2 
182.26 
Insoluble 
Soluble 
226-227 
 
NMR 
96 % 
1.450-1.456 
0.901-0.907 
 
 
09.189 
823 
1-Phenylpropyl butyrate O
O
2424 
628 
10031-86-4 
Liquid 
C13H18O2 
206.28 
Insoluble 
Miscible 
282 
 
IR 
97 % 
1.486-1.491 
0.986-0.992 
 
Racemate (EFFA, 2010a). 
09.200 
816 
1-Methyl-3-phenylpropyl acetate O
O
2882 
671 
10415-88-0 
Liquid 
C12H16O2 
192.26 
Insoluble 
Miscible 
72-74 (0.7 hPa) 
 
NMR MS 
98 % 
1.498-1.505 
0.975-0.980 
 
Racemate. 
09.230 
1094 
Cyclohexyl butyrate 
O
O 2351 
2082 
1551-44-6 
Liquid 
C10H18O2 
170.25 
Practically insoluble 
Miscible 
212 
 
NMR 
98 % 
1.439-1.451 
0.953-0.959 
 
 
09.239 
1358 
Methyl 2-undecynoate O
O
 
2751 
2111 
10522-18-6 
Liquid 
C12H20O2 
196.29 
Insoluble 
Soluble 
230 
 
NMR 
97 % 
1.443-1.449 
0.915-0.921 
(20°) 
 
 
09.288 
731 
4-(4-Acetoxyphenyl)butan-2-one O
O
O
 
3652 
 
3572-06-3 
Liquid 
C12H14O3 
206.24 
Insoluble 
Miscible 
155 (3 hPa) 
 
IR 
93 % 
1.506-1.512 
1.096-1.100 
 
According to JECFA: Min. 
assay value is "93 (min. 95 
% combined o- and p- 
isomers)" and "contains 2-5 
% ortho isomer". 
09.294 
863 
2-Methylbenzyl acetate 
O
O
 
3702 
 
17373-93-2 
Liquid 
C10H12O2 
164.20 
Insoluble 
Miscible 
215-222 
 
IR 
98 % 
1.500-1.510 
1.024-1.040 
 
CAS-nr refers to: 2-methyl 
(= ortho-) isomer. Min. 
assay value is 98 % (sum of 
positional isomers: relative 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
ratio of o-, m- and p-isomers 
31-33 % of each isomer, 
respectively) (EFFA, 
2010a). 
09.319 
1412 
Bornyl butyrate 
O
_____
O
 
3907 
 
13109-70-1 
Liquid 
C14H24O2 
224.34 
Slightly soluble 
Soluble 
247 
 
MS 
97 % 
1.462-1.469 
0.981-0.991 
 
CASrn in Register refers to 
(1R,2S,4R)-stereoisomer. 
Register name to be changed 
accordingly.  
09.371 
1193 
Ethyl deca-2,4,7-trienoate O
O  
3832 
10576 
78417-28-4 
Liquid 
C12H18O2 
194.28 
Soluble 
Soluble 
134 (18 hPa) 
 
IR NMR 
95 % 
1.547-1.554 
0.933-0.939 
 
Mixture of (Z)- and (E)-
isomer for all three C=C 
double bonds (EFFA, 
2010a).  
CASrn in Register does not 
specify stereoisomeric 
composition. 
Composition of 
stereoisomeric mixture to be 
specified. 
09.443 
939 
Isopentyl pyruvate O
O
O
 
2083 
431 
7779-72-8 
Liquid 
C8H14O3 
158.20 
Insoluble 
Miscible 
185 
 
IR 
97 % 
1.417-1.424 
0.972-0.980 
 
 
09.488 
966 
Ethyl cyclohexanepropionate 
O
O 2431 
2095 
10094-36-7 
Liquid 
C11H20O2 
184.28 
Insoluble 
Miscible 
91 (10 hPa) 
 
NMR 
98 % 
1.444-1.452 
0.926-0.932 
 
 
09.501 
835 
Ethyl 2-acetyl-3-phenylpropionate O
O
O
2416 
2241 
620-79-1 
Liquid 
C13H16O3 
220.27 
Insoluble 
Miscible 
276 
 
IR 
97 % 
1.498-1.502 
1.033-1.037 
 
Racemate (EFFA, 2010a).  
09.534 
963 
Ethyl cyclohexanecarboxylate 
O
O
 
3544 
11916 
3289-28-9 
Liquid 
C9H16O2 
156.22 
Insoluble 
Miscible 
82 (16 hPa) 
 
IR NMR 
99 % 
1.447-1.454 
0.966-0.978 
(20°) 
 
 
09.552 
914 
3-Oxodecanoic acid glyceride 
O
O O
OH
OH
 
3767 
10650 
91052-69-6 
Solid 
C13H24O5 
260.33 
Insoluble 
Slightly soluble 
n.a. 
57-60 
NMR 
95 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a). 
According to JECFA: Min. 
Assay value is "95 by ester 
determination". 
09.555 
910 
3-Oxohexanoic acid glyceride 
O
OH
OHO O
 
3770 
10653 
91052-72-1 
Solid 
C9H16O5 
316.36 
Insoluble 
Slightly soluble 
n.a. 
41-44 
NMR 
95 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a). 
According to JECFA: Min. 
Assay value is "95 by ester 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
determination". 
09.557 
916 
3-Oxotetradecanoic acid glyceride 
O
OH
OHO O
 
3772 
10655 
91052-73-2 
Solid 
C17H32O5 
316.44 
Insoluble 
n.a. 
n.a. 
73-75 
NMR 
95 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a). 
According to JECFA: Min. 
Assay value is "95 by ester 
determination". 
09.561 
1538 
Hex-3(cis)-enyl anthranilate 
NH2 O
O
 
3925 
10676 
65405-76-7 
Liquid 
C13H17O2N 
219.29 
Insoluble 
Soluble 
160 (7 hPa) 
 
IR NMR 
98 % 
1.545-1.554 
1.047-1.054 
 
 
09.639 
1191 
Methyl deca-2,4-dienoate 
(2E,4Z) isomer shown
O
O
 
3859 
 
4493-42-9 
Liquid 
C11H18O2 
182.26 
Insoluble 
Soluble 
67 (1 hPa) 
 
IR NMR 
93 5 
1.488-1.494 
0.917-0.923 
 
CASrn refers to (2E, 4Z)-
isomer. Material in 
commerce is min. 93 % pure 
(2E,4Z)-isomer.  Min. Purity 
> 95 % (sum of isomers: 
other isomer mainly 
(2E,4E)-isomer (< 5 
%))(EFFA, 2010a). Registed 
name to ge changed to 
Methyl (E,Z)-deca-2,4-
dienoate. 
09.658 
1142 
1-Methylbutyl butyrate 
O
O
 
3893 
10763 
60415-61-4 
Liquid 
C9H18O2 
158.24 
Insoluble 
50% Soluble 
185-186 
 
IR NMR MS 
99 % 
1.409-1.415 
0.862-0.868 
 
Racemate (EFFA, 2010a). 
09.702 
1010 
Propyl phenylacetate 
O
O
 
2955 
229 
4606-15-9 
Liquid 
C11H14O2 
178.23 
Insoluble 
Miscible 
253 
 
NMR 
97 % 
1.489-1.497 
0.985-0.995 
(15.5°) 
 
 
09.722 
1541 
Cyclohexyl anthranilate 
NH2
O
O
 
2350 
257 
7779-16-0 
Liquid 
C13H17O2N 
219.29 
Insoluble 
Soluble 
318 
 
NMR 
97 % 
1.571-1.577 
1.015-1.021 
 
 
09.746 
643 
Methyl 3-phenylpropionate 
O
O
2741 
427 
103-25-3 
Liquid 
C10H12O2 
164.20 
Insoluble 
Miscible 
238-239 
 
IR 
98 % 
1.499-1.505 
1.037-1.045 
 
 
09.780 
760 
Cinnamyl benzoate 
O
O
Trans form shown
 
4703 
743 
5320-75-2 
Solid 
C16H14O2 
238.29 
Insoluble 
Miscible 
335 
31 
IR 
98 % 
n.a. 
n.a. 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
09.783 
1008 
Methyl phenylacetate 
O
O
 
2733 
2155 
101-41-7 
Liquid 
C9H10O2 
150.18 
Insoluble 
1 ml in 6 ml 60% 
ethanol 
215 
 
IR 
97 % 
1.504-1.510 
1.061-1.067 
 
 
09.801 
1544 
2-Naphthyl anthranilate 
H2N
O
O
2767 
11862 
63449-68-3 
Liquid 
C17H13O2N 
263.30 
Insoluble 
Soluble 
340 
 
NMR 
98 % 
1.531-1.539 
1.300-1.308 
 
 
09.803 
862 
Propylene glycol dibenzoate O
O
O
O
3419 
10890 
19224-26-1 
Liquid 
C17H16O4 
284.31 
Insoluble 
Miscible 
232 (16 hPa) 
 
IR 
96 % 
1.542-1.547 
1.157-1.163 
 
Racemate. 
09.807 
907 
o-Tolyl salicylate OH O
O
3734 
 
617-01-6 
Solid 
C14H12O3 
228.25 
Insoluble 
Soluble 
180 (3 hPa) 
25 
NMR 
99 % 
1.576-1.584 
1.164-1.174 
 
 
09.812 
861 
Glyceryl tribenzoate 
O
O
O
O
O
O
3398 
10656 
614-33-5 
Solid 
C24H20O6 
404.42 
Insoluble 
Slightly soluble 
n.a. 
68-72 
IR 
95 % 
n.a. 
n.a. 
 
 
10.050 
1161 
Hexahydro-3,6-dimethyl-2(3H)-
benzofuranone 
O
O
 
4032 
 
92015-65-1 
Liquid 
C10H16O2 
168.24 
Soluble 
Soluble 
274-276 (17hPa) 
 
IR NMR 
99.4 % 
1.464-1.470 
1.016-1.022 
(20°) 
 
Mixture of optical isomers 
(diastereoisomers) (EFFA, 
2010a).  
CASrn in Register does not 
specify stereoisomeric 
composition. 
Composition of 
stereoisomeric mixture to be 
specified. 
10.061 
1159 
cis-5-Hexenyldihydro-5-
methylfuran-2(3H)-one 
O
O
 
3937 
 
70851-61-5 
Liquid 
C11H18O2 
182.26 
Insoluble 
Soluble 
150 (8 hPa) 
 
IR NMR 
97 % 
1.463-1.468 
0.960-0.967 
 
Racemate of (Z)-isomer 
(EFFFA, 2010a).  
CASrn in Register does not 
specify stereoisomeric 
composition. 
10.069 
1158 
3-Methyl gamma-decalactone O O 3999 
 
67663-01-8 
Liquid 
C11H20O2 
184.28 
Insoluble 
Soluble 
110-115 (5 hPa) 
 
NMR 
1.446-1.452 
0.938-0.944 
 
Composition: cis-3-methyl-
gamma-decalactone (40-54 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
94 % %), trans-3-methyl-gamma-
decalactone (40-54 %) and 
Heptan-1-ol (1-2 %) (EFFA, 
2010a).  
10.070 
1157 
4-Methyl-5-hexen-1,4-olide O O
 
4051 
 
1073-11-6 
Liquid 
C7H10O2 
126.15 
Insoluble 
Soluble 
219 
 
IR NMR 
97 % 
1.457-1.462 
1.015-1.025 
(20°) 
 
Racemate (EFFA, 2010a).  
10.072 
1167 
Dimethyl-3,6-benzo-2(3H)-furanone O
O
 
3863 
 
65817-24-5 
Liquid 
C10H10O2 
162.19 
Insoluble 
Soluble 
64 (0.1 hPa) 
 
IR NMR 
98 % 
1.518-1.524 
1.099-1.104 
 
Racemate (EFFA, 2010a). 
13.027 
1485 
2-Pentyl-5 or 6-keto-1,4-dioxane 
O
O O
 
2076 
2205 
65504-96-3 
Liquid 
C9H16O3 
172.22 
Slightly soluble 
Soluble 
101-103 (20hPa) 
 
NMR 
97 % 
1.480-1.486 
1.288-1.294 
 
Mixture of 5-pentyl- and 6-
pentyl-1,4-dioxane-2-one 68 
% 5- & 29 % 6-isomer (sum 
isomers > 95 %).  
Racemate (EFFA, 2010).  
13.028 
1484 
2-Butyl-5 or 6-keto-1,4-dioxane 
O
O O
 
2204 
2206 
65504-45-2 
Liquid 
C8H14O3 
158.20 
Slightly soluble 
Soluble 
98-99 (17 hPa) 
 
NMR 
97 % 
1.472-1.478 
1.292-1.296 
 
Mixture of 5-butyl- and 6-
butyl-1,4-dioxane-2-one: 65 
% 5- and 32 % 6-isomer 
(sum isomers > 95%). 
Racemate (EFFA, 2010a). 
Change CASrn to 65504-95-
2. 
13.060 
1447 
Tetrahydrofurfuryl cinnamate 
O
O
O
 
3320 
11821 
65505-25-1 
Liquid 
C14H16O3 
232.28 
Insoluble 
Soluble 
>300 
 
NMR 
95 % 
1.593-1.600 
1.107-1.113 
 
Racemate of mixture of (Z)- 
and (E)-isomer (EFFA, 
2010a).  
Composition of 
stereoisomeric mixture to be 
specified.  
13.161 
1166 
Octahydrocoumarin O O
 
3791 
 
4430-31-3 
Liquid 
C9H14O2 
154.21 
Insoluble 
Soluble 
293-298 
 
NMR 
99 % 
1.489-1.493 
1.090-1.096 
 
Mixture of optical isomers 
(diastereoisomers) (EFFA, 
2010a).  
Composition of 
stereoisomeric mixture to be 
specified. 
14.014 
1566 
5,7-Dihydro-2-methylthieno(3,4-
d)pyrimidine 
N
N
S
 
3338 
720 
36267-71-7 
Solid 
C7H8N2S 
152.22 
Very slightly soluble 
Soluble 
 
64 
NMR 
98 % 
n.a. 
n.a. 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
14.029 
1568 
1-Phenyl-(3 or 5)-propylpyrazole 
N
N
1-Phenyl-3-propylpyrazole shown  
3727 
2277 
65504-93-0 
Liquid 
C12H14O2 
190.24 
Insoluble 
Soluble 
182-193 
 
NMR 
96 % 
1.428-1.436 
1.078-1.081 
 
CASrn in Register 
corresponds to an 
incompletely defined 
structure. 
14.045 
1305 
2-Acetyl-1-ethylpyrrole 
N
O
 
3147 
11371 
39741-41-8 
Liquid 
C8H11ON 
137.18 
Slightly soluble 
Soluble 
209-211 
 
NMR 
98 % 
1.550-1.556 
1.052-1.058 
Slightly soluble in  water 
(EFSA, 2010a). 
 
 
14.058 
1311 
2-Isobutylpyridine N
 
3370 
11395 
6304-24-1 
Liquid 
C9H13N 
135.21 
Insoluble 
Soluble 
181 
 
NMR 
97 % 
1.480-1.486 
0.894-0.900 
 
 
14.059 
1312 
3-Isobutylpyridine N
 
3371 
11396 
14159-61-6 
Liquid 
C9H13N 
135.21 
Insoluble 
Soluble 
68-68.5 (10hPa) 
 
NMR 
97 % 
1.488-1.494 
0.898-0.904 
 
 
14.070 
1565 
4-Acetyl-2-methylpyrimidine 
N
N
O
 
3654 
 
67860-38-2 
Liquid 
C7H8ON2 
136.15 
Slightly soluble 
Soluble 
87-89 (13 hPa) 
 
NMR 
99 % 
1.501-1.507 
1.096-1.102 
 
 
14.164 
1322 
2-Propylpyridine N
 
 
 
622-39-9 
Liquid 
C8H11N 
121.20 
Slightly soluble 
Soluble 
169-171 
 
NMR 
98 % 
1.490-1.496 
0.907-0.917 
 
 
15.002 
1057 
2-Methyl-5-methoxythiazole 
N
SO
 
3192 
736 
38205-64-0 
Liquid 
C5H7ONS 
129.18 
Insoluble 
Miscible 
117 (44 hPa) 
 
MS 
98 % 
1.515-1.520 
1.146-1.154 
 
 
15.008 
1053 
2-Thienyl disulfide 
S S
S
S
 
3323 
2333 
6911-51-9 
Solid 
C8H6S4 
230.39 
 
Soluble 
n.a. 
55-60 
NMR 
98 % 
n.a. 
n.a. 
SW 7). 
 
15.027 
1042 
2-Propionylthiazole 
N
S
O
 
3611 
 
43039-98-1 
Liquid 
C6H7ONS 
141.19 
Insoluble 
Miscible 
95 (1 hPa) 
 
IR NMR MS 
98 % 
1.528-1.533 
1.205-1.210 
 
 
16.039 
933 
Potassium 2-(1'-
ethoxy)ethoxypropanoate K
+
O
O-O
O
 
3752 
 
 
Solid 
C7H13KO4 
200.28 
Freely soluble 
Slightly soluble 
n.a. 
n.a. 
NMR 
98 % 
n.a. 
n.a. 
 
Mixture of diastereomeric 
isomers (EFFA, 2010a).  
Composition of 
stereoisomeric mixture to be 
specified. According to 
JECFA: Min. Assay value is 
"98 by acid/base titration". 
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Table 1: Specification Summary of the Substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
CASrn to be introduced into 
the Register. 
16.041 
1029 
Sodium 2-(4-
methoxyphenoxy)propionate 
O
O
ONa
O
3773 
 
13794-15-5 
Solid 
C10H11O4,Na
+ 
218.19 
Soluble 
Miscible 
n.a. 
190 
IR 
98 % 
n.a. 
n.a. 
 
Racemate. 
16.056 
1435 
Taurine 
NH2
S
OH
O
O  
3813 
 
107-35-7 
Solid 
C2H7O3NS 
125.15 
Soluble 
Soluble 
 
>300° 
NMR 
98 % 
n.a. 
n.a. 
 
 
16.075 
892 
Ethyl vanillin beta-D-
glucopyranoside 
O
O
O
OH
OH
HO
O
HO
3801 
 
 
Solid 
C15H20O8 
328.32 
Slightly soluble 
Slightly soluble 
n.a. 
199-200 
NMR 
99 % 
n.a. 
n.a. 
 
CASrn to be included in the 
Register: 122397-96-0. 
According to JECFA: 
Boiling point is "n/a 
(decomposes on heating)". 
17.001 
1418 
beta-Alanine 
NH2 OH
O
 
3252 
 
107-95-9 
Solid 
C3H7O2N 
89.09 
Soluble 
Slightly soluble 
 
202-207 
NMR 
97 % 
n.a. 
n.a. 
 
 
17.003 
1438 
l-Arginine 
NH2 NH
OH
ONH
NH2  
3819 
11890 
74-79-3 
Solid 
C6H14O2N4 
174.20 
Soluble 
Slightly soluble 
 
222 
MS 
98 % 
n.a. 
n.a. 
 
According to JECFA: "Sp 
rotation = +15 to +17° (20°, 
6N HCl)". Register name to 
be changed to L-Arginine. 
17.015 
1427 
S-Methylmethioninesulphonium 
chloride 
S+
OH
O
NH2
Cl-
 
3445 
761 
1115-84-0 
Solid 
C6H14O2NS 
199.70 
Soluble 
Soluble 
 
139 
NMR 
98 % 
n.a. 
n.a. 
 
Register name to be changed 
to L- 
Methylmethioninesulpho-
nium chloride. 
17.026 
1439 
l-Lysine 
H2N
OH
O
NH2  
3847 
11947 
56-87-1 
Solid 
C6H14O2N2 
146.19 
Soluble 
Slightly soluble 
 
215 
MS 
97 % 
n.a. 
n.a. 
 
According to JECFA: 
"Sp.rotation = +12.5 to 
+13.5° (23°, 6N HCl)". 
Register name to be changed 
to L-Lysine. 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
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6) Stereoisomeric composition not specified. 
7) SW: Missing data on solubility. 
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TABLE 2: SUMMARY OF SAFETY EVALUATIONS 
Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
02.051 
675 
5-Phenylpentan-1-ol 
OH  
1.2 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
02.141 
986 
2-(6,6-Dimethylbicyclo[3.1.1]hept-2-
en-2-yl)ethan-1-ol 
OH  
33 
0.01 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
02.189 
1283 
Nona-3,6-dien-1-ol OH
(Z,Z)-isomer shown  
0.13 
0.9 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Register name to be 
changed to (Z,Z)-Nona-3,6-
dien-1-ol.  
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
02.224 
1408 
3-(1-Menthoxy)propane-1,2-diol 
O OH
OH  
4.1 
789 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Racemate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
02.243 
1284 
(E,Z)-3,6-Nonadien-1-ol OH  0.61 
0.9 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
02.246 
1416 
p-Menthane-3,8-diol 
OH
OH  
39 
18 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Racemate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
02.254 
1411 
3-Menthoxy-2-methylpropane-1,2-
diol 
O OH
OH  
61 
500 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Register name to be 
changed to (1R,2S,5S)-3-
Menthoxy-2-
methylpropane-1,2-diol.  
No safety concern at the 
estimated level of intake 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
based on the MSDI 
approach. 
 
04.037 
720 
4-Ethoxyphenol 
OHO
 
0.37 
0.4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
04.052 
723 
4-Ethyl-2,6-dimethoxyphenol 
OH
O
O 1.3 
1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
04.053 
722 
4-Methyl-2,6-dimethoxyphenol 
OH
O
O 0.054 
0.04 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
04.056 
724 
2,6-Dimethoxy-4-propylphenol 
OH
O
O 0.061 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
05.094 
680 
3-(4-
Isopropylphenyl)propionaldehyde 
O
 
0.012 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
06.027 
1005 
4,5-Dimethyl-2-benzyl-1,3-dioxolan 
O
O  
0.12 
1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Racemate (EFFA, 2010a). 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
06.040 
913 
1,2,3-Tris([1'-ethoxy]-
ethoxy)propane 
O
O
O
O
O
O
0.12 
140 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Stereoisomeric composition 
to be specified. 
06.081 
943 
1-Ethoxy-1-(3-hexenyloxy)ethane O
O  
4.6 
0 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
08.071 
883 
p-Anisic acid 
O
OH
O 1.7 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
08.073 
1372 
Dec-2-enoic acid 
OH
O
(E)-isomer shown  
0.012 
4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Composition of 
stereoisomeric mixture to 
be specified. 
08.076 
908 
2,4-Dihydroxybenzoic acid 
HO
OH O
OH
5.5 
6 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
08.085 
1176 
Hexa-2,4-dienoic acid 
OH
O
 
61 
6 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Register name to be 
changed to (E,E)-2,4-
hexadienoic acid. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
08.092 
882 
3-Methoxybenzoic acid 
O
OH
O 0.012 
0.01 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
08.123 
1373 
trans-2-Heptenoic acid 
OH
O
 
4.7 
4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Stereoisomeric composition 
to be specified. 
09.036 
699 
p-Tolyl acetate 
O
O
 
0.047 
70 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.071 
642 
3-Phenylpropyl hexanoate 
O
O
0.24 
0.4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.084 
637 
3-Phenylpropyl formate 
OO
 
0.012 
0.8 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.102 
704 
p-Tolyl dodecanoate O
O
0.24 
0.3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
No safety concern at the 
estimated level of intake 
based on the MSDI 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
approach approach. 
09.145 
874 
p-Anisyl propionate 
O
O
O 0.42 
5 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.153 
1392 
Bornyl valerate 
O
_____
O
 
3.7 
5 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Racemate (EFFA, 2010a). 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
09.157 
1352 
Ethyl 2-nonynoate O
O
 
1.1 
0.9 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.189 
823 
1-Phenylpropyl butyrate O
O
0.24 
0.3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.200 
816 
1-Methyl-3-phenylpropyl acetate O
O
6.1 
7 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.230 
1094 
Cyclohexyl butyrate 
O
O 0.89 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.239 
1358 
Methyl 2-undecynoate O
O
 
0.012 
0.04 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.288 
731 
4-(4-Acetoxyphenyl)butan-2-one O
O
O
0.12 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.294 
863 
2-Methylbenzyl acetate 
O
O
2.4 
3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
09.319 
1412 
Bornyl butyrate 
O
_____
O
 
6.1 
9 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
CASrn refers to 
(1R,2S,4R)-stereoisomer. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.371 
1193 
Ethyl deca-2,4,7-trienoate O
O  
0.024 
0.4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Composition of 
stereoisomeric mixture to 
be specified. 
09.443 
939 
Isopentyl pyruvate O
O
O
 
17 
0 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.488 
966 
Ethyl cyclohexanepropionate 
O
O 0.12 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.501 
835 
Ethyl 2-acetyl-3-phenylpropionate O
O
O
0.37 
0.4 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.534 
963 
Ethyl cyclohexanecarboxylate 
O
O
 
0.24 
0.1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.561 
1538 
Hex-3(cis)-enyl anthranilate 
NH2 O
O
 
0.012 
53 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.639 
1191 
Methyl deca-2,4-dienoate 
(2E,4Z) isomer shown
O
O
 
0.097 
1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.658 
1142 
1-Methylbutyl butyrate 
O
O
 
0.47 
1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Racemate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.702 
1010 
Propyl phenylacetate 
O
O
 
0.13 
0.3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
09.722 
1541 
Cyclohexyl anthranilate 
NH2
O
O
 
0.0073 
0.007 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.746 
643 
Methyl 3-phenylpropionate 
O
O
0.12 
3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.780 
760 
Cinnamyl benzoate 
O
O
Trans form shown
1.2 
1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Composition of 
stereoisomeric mixture to 
be specified. 
09.783 
1008 
Methyl phenylacetate 
O
O
 
95 
20 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.801 
1544 
2-Naphthyl anthranilate 
H2N
O
O
1.3 
2 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.803 
862 
Propylene glycol dibenzoate O
O
O
O
 
13 
14 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Racemate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.807 
907 
o-Tolyl salicylate OH O
O
28 
30 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.812 
861 
Glyceryl tribenzoate 
O
O
O
O
O
O
45 
49 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
10.061 
1159 
cis-5-Hexenyldihydro-5-
methylfuran-2(3H)-one 
O
O
 
100 
13 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
10.069 
1158 
3-Methyl gamma-decalactone O O
 
4.5 
5 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
10.070 
1157 
4-Methyl-5-hexen-1,4-olide O O
 
2.2 
3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
16.039 
933 
Potassium 2-(1'-
ethoxy)ethoxypropanoate K
+
O
O-O
O
 
1200 
1400 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Composition of 
stereoisomeric mixture to 
be specified. 
16.056 
1435 
Taurine 
NH2
S
OH
O
O  
770 
217 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at 
estimated level of intake 
based on the MSDI 
approach. 
17.001 
1418 
beta-Alanine 
NH2 OH
O
 
360 
13 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at 
estimated level of intake 
based on the MSDI 
approach. 
06.019 
840 
1-Benzyloxy-1-(2-
methoxyethoxy)ethane 
O
O
O
 
1.2 
1 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. EFSA based the 
safety evaluation on 
NOAELs derived from 
studies performed with the 
hydrolysis products. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
08.004 
930 
Lactic acid OH
OH
O  
19000 
47000 
Class I 
A3: Intake above threshold, 
A4: Endogenous 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
17.003 
1438 
l-Arginine 
NH2 NH
OH
ONH
NH2  
1000 
57 
Class I 
No evaluation 
 The substance is a 
macronutrient which is a 
normal component of food 
protein and, as such, human 
exposure through food is 
orders of magnitude higher 
than the anticipated level of 
exposure from use as a 
flavouring substance. 
No safety concern at 
estimated level of intake 
based on the MSDI 
approach. 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
17.026 
1439 
l-Lysine 
H2N
OH
O
NH2  
1000 
57 
Class I 
No evaluation 
 The substance is a 
macronutrient which is a 
normal component of food 
protein and, as such, human 
exposure through food is 
orders of magnitude higher 
than the anticipated level of 
exposure from use as a 
flavouring substance. 
No safety concern at 
estimated level of intake 
based on the MSDI 
approach. 
 
04.093 
888 
Butyl vanillyl ether 
HO
O
O
 
1.4 
0.1 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
07.069 
1121 
Tetrahydro-pseudo-ionone O
 
0.012 
0.01 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
07.070 
830 
3-Benzylheptan-4-one O 0.05 
1 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
07.100 
1119 
5-Methylhex-5-en-2-one O
 
0.24 
0.3 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
14.045 
1305 
2-Acetyl-1-ethylpyrrole 
N
O
 
0.12 
0.009 
Class II 
A3: Intake below threshold 
4) Not metabolised to 
innocouos products - EFSA 
evaluated at step B4: No, 
no adequate NOAEL could 
be established 
 
14.059 
1312 
3-Isobutylpyridine N
 
0.049 
0.07 
Class II 
A3: Intake below threshold 
4) Concluded at step B4 to be 
of no safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
14.164 
1322 
2-Propylpyridine N
 
0.61 
0.9 
Class II 
A3: Intake below threshold 
4) Concluded at step B4 to be 
of no safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Flavouring Group Evaluation 96
 
 
49 EFSA Journal 2011; 9(12):1924 
Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
16.075 
892 
Ethyl vanillin beta-D-
glucopyranoside 
O
O
O
OH
OH
HO
O
HO
28 
30 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
CASrn to be included in the 
Register: 122397-96-0. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
14.070 
1565 
4-Acetyl-2-methylpyrimidine 
N
N
O
 
0.011 
0.01 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
15.027 
1042 
2-Propionylthiazole 
N
S
O
 
0.056 
0.2 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
10.050 
1161 
Hexahydro-3,6-dimethyl-2(3H)-
benzofuranone 
O
O
 
8.0 
12 
Class III 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
CASrn in Register does not 
specify stereoisomers.  
Composition of 
stereoisomeric mixture to 
be specified. 
 
13.027 
1485 
2-Pentyl-5 or 6-keto-1,4-dioxane 
O
O O
 
0.12 
0.2 
Class III 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
13.028 
1484 
2-Butyl-5 or 6-keto-1,4-dioxane 
O
O O
 
0.43 
0.5 
Class III 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach.  
13.060 
1447 
Tetrahydrofurfuryl cinnamate 
O
O
O 0.012 
0.01 
Class III 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Composition of 
stereoisomeric mixture to 
be specified.  
13.161 
1166 
Octahydrocoumarin O O
 
1.3 
0.07 
Class III 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
14.058 
1311 
2-Isobutylpyridine N
 
0.0061 
0.9 
Class III 
A3: Intake below threshold 
4) Concluded at step B4 to be 
of no safety concern at the 
estimated level of intake 
based on the MSDI 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
approach 
16.041 
1029 
Sodium 2-(4-
methoxyphenoxy)propionate 
O
O
ONa
O  
0.012 
6 
Class III 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Racemate. 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
17.015 
1427 
S-Methylmethioninesulphonium 
chloride 
S+
OH
O
NH2
Cl-
 
350 
75 
Class III 
A3: Intake below threshold 
4) Concluded at step B4 to be 
of no safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
Register name to be 
changed to L- 
Methylmethioninesulphoni
um chloride.  
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
09.552 
914 
3-Oxodecanoic acid glyceride 
O
O O
OH
OH
 
52 
270 
Class III 
A3: Intake above threshold, 
A4: Endogenous 
4) No safety concern at the 
estimated level of intake 
based in the MSDI 
approach. EFSA concluded 
at step A3: No 
Racemate (EFFA, 2010a). 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.555 
910 
3-Oxohexanoic acid glyceride 
O
OH
OHO O
 
0.061 
270 
Class III 
A3: Intake above threshold, 
A4: Endogenous 
4) No safety concern at the 
estimated level of intake 
based in the MSDI 
approach. EFSA concluded 
at step A3: No 
Racemate (EFFA, 2010a). 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
09.557 
916 
3-Oxotetradecanoic acid glyceride 
O
O
O O 0.012 
270 
Class III 
A3: Intake above threshold, 
A4: Endogenous 
4) No safety concern at the 
estimated level of intake 
based in the MSDI 
approach. EFSA concluded 
at step A3: No 
Racemate (EFFA, 2010a). 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
10.072 
1167 
Dimethyl-3,6-benzo-2(3H)-furanone O
O
 
0.84 
2 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 
 
14.014 
1566 
5,7-Dihydro-2-methylthieno(3,4-
d)pyrimidine 
N
N
S
 
0.012 
0.4 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
14.029 
1568 
1-Phenyl-(3 or 5)-propylpyrazole 
N
N
1-Phenyl-3-propylpyrazole shown
0.17 
0.2 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
CASrn in the Register 
corresponds to an 
incompletely defined 
structure. 
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Table 2: Summary of Safety Evaluation of the JECFA substances in the present group 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on the 
material of commerce 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
CASrn in Register 
corresponds to an 
incompletely defined 
structure. 
 
 
15.002 
1057 
2-Methyl-5-methoxythiazole 
N
SO
 
0.012 
0.01 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
15.008 
1053 
2-Thienyl disulfide 
S S
S
S
 
0.061 
0.07 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL 
exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach 
No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800, Class II = 540, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
 
ND: not determined. 
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ANNEX I 
 
 
Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class?
Data must be available on the  
substance or closely related  
substances to perform a safety  
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern Is  the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3.
Step B4.
 Yes  No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
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ABBREVIATIONS 
ADI  Accetable Daily Intake 
BW  Body weight 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CoE  Council of Europe 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
ID  Identity 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
No  Number 
NOAEL No observed adverse effect level 
NTP  National Toxicology Program 
SCF  Scientific Committee on Food 
WHO  World Health Organisation 
